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This study investigates frailty, defined as the accumulation of deficits in physiological
functioning, by applying the Skeletal Frailty Index (SFI) to a skeletal sample (N=67) recovered
from the Mississippi State Asylum (MSA), and in a comparative sample, the Terry Collection.
The SFI was statistically modified to increase its utility here. Variables that influence frailty,
including age, sex, stress in early-life, and resilience, were assessed relative to four SFIs:
Overall, Nutritional, Activity, and Infection. This study finds that the predicted relationships
between the SFIs and the aforementioned variables are largely absent in the MSA sample. When
compared to individuals in the Terry, MSA individuals generally manifest a lower prevalence of
biomarkers but have reduced longevity, which suggests that MSA patients experienced higher
frailty and lower resilience. This may be attributable to negative biosocial experiences over the
life course prior to institutionalization, but primarily to often-negative environmental conditions
during institutionalization.
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CHAPTER I
INTRODUCTION
1.1

Problem Statement
There are many ways to define and measure frailty, which is a commonly used concept in

clinical medicine and public health (Dent et al. 2016; Gahbauer et al. 2008; Rockwood and
Howlett 2019; Rockwood et al. 2005; Xue 2011). For instance, frailty has been defined as a
“clinically recognizable state of increased vulnerability resulting from aging-associated decline
in reserve and function across multiple physiologic systems such that the ability to cope with
every day or acute stressors is comprised” (Xue 2011, p. 1). More simply, it has also been
defined as “a state of increased vulnerability to adverse outcomes” (Gahbauer et al. 2008, p. 1).
One particularly common definition, which is employed here, holds that frailty is a measure of
accumulated or layered deficits in physiological functioning, often across physiological systems,
that tends to increase with age (Cornman et al. 2017). In living individuals, frailty is often
measured by assessing and summing the presence of several biomarkers (e.g., grip strength,
balance, blood pressure) to create a frailty index (Dent et al. 2016; Gahbauer et al. 2008;
Rockwood et al. 2005; Xue 2011). In frailty indices, the more biomarkers that an individual
exhibits, the more frail they are. This method of measuring frailty allows investigators to
understand the physiological consequences of lifelong health experiences and to gain a more
holistic understanding of an individual’s health. Further, frailty indices have been widely used in
public health and clinical medicine both as an investigative tool and to inform treatment and
1

prevention interventions (Binru et al. 2019; Burn et al. 2018; Hoogendijk et al. 2018). This is in
part because measuring frailty provides a way to overcome some of the difficulties that are
involved in defining and operationalizing the concept of health, which is an obstacle faced across
health-related fields (see Background) (Huber et al. 2011).
Frailty has been investigated in skeletal individuals as well. To do so, most researchers
use age-at-death as the measure of frailty (e.g., frail individuals die at younger ages), which
equates frailty with the risk of mortality. In turn, they assess frailty against demographic
characteristics, such as sex, and skeletally evident health conditions, such as indicators of chronic
and/or episodic physiological stress (hereafter referred to as “stress”)(e.g., periosteal
reactions)(e.g., Armelagos et al. 2009; DeWitte 2014; 2017; DeWitte and Bekvalac 2010; 2011;
Watts 2011; 2015; Yaussy et al. 2016). Other scholars in bioarchaeology have used evidence of
accumulated experiences of stress (e.g., biomarkers) as a measure of frailty. Doing so provides a
way to closely approximate common definitions of frailty applied to living individuals for use
in studying skeletal individuals. Marklein and colleagues (2017; 2016), for instance, compiled
biomarkers representing stress into a frailty index, the Skeletal Frailty Index (SFI), which can be
applied to skeletal material.
The SFI, of which this study employs a modified version, is intended to provide
bioarchaeologists and those in related fields with a means of measuring longitudinal, cumulative
health experiences on both the individual- and population-level in past populations (Marklein et
al. 2016). Importantly, the SFI makes use of a life-history approach. Life-history approaches are
based on understanding that individual experiences of health are not isolated incidents, but rather
cumulative and interrelated experiences that are historically and socioeconomically contingent
(Agarwal 2016). Specifically, the SFI empirically measures cumulative experiences of stress
2

over the life course by assessing the presence or absence of thirteen macroscopic skeletal and
oral biomarkers of non-specificstress. These include femoral length, femoral head diameter,
linear enamel hypoplasias (LEH), periodontal disease (PD), periosteal reactions, porotic
hyperostosis (PH)/cribra orbitalia (CO), rickets/osteomalacia, neoplasms, osteoporosis,
osteoarthritis (OA), intervertebral disk disease (IVD), rotator cuff disease (RCD), and fractures
(Marklein et al. 2016). In total, these biomarkers represent a variety of health experiences that
can occur across physiological systems and throughout the life course, including growth
disruption, nutritional deﬁciency, infection, activity, and trauma (Marklein et al. 2016). In this
way, the SFI meets standard requirements for frailty indices in modern populations (Gahbauer et
al. 2008). When their presence (1) and absence (0) is summed, the resulting value (0 (no
biomarkers present) to 13 (all biomarkers present)) represents a measure of frailty. The SFI is
comparable to frailty indices used in modern populations because it measures health experiences
independent of age-at-death (Marklein et al. 2016). Importantly, because the SFI uses biomarkers
that are indicative of poor or adverse environmental conditions and experiences of stress in earlylife (e.g., growth disruption) and health experiences in adulthood (e.g., osteoarthritis, rotator cuff
disease), the SFI can be used to assess variance in frailty relative to various demographic factors,
such as age and sex (Marklein et al. 2016), as well as other aspects of health, such as negative
environmental conditions in early-life and resilience, which is briefly defined here as resistance
to and recovery from stressors (Witham and Sayer 2015). As these variables (e.g., age, sex,
early-life stress, resilience) are known to influence frailty, they must be considered in any
investigation of frailty.
Regarding age, previous studies have produced conflicting findings. Public health and
clinical medical studies have found that frailty increases with age, as older individuals have
3

encountered a greater number of stressors (e.g., Rockwood and Howlett 2019; Rockwood et al.
2005). Some analyses of frailty relative to age in past populations have found that frail
individuals die young (e.g., DeWitte 2010; 2017; DeWitte and Bekvalac 2010; Wood et al.
1992), but others have found that older individuals are frailer due to encountering more stressors
(e.g., Griffin et al. 2018; Guatelli-Steinberg and Lukacs 1999). This means that the relationship
between frailty and age is somewhat ambiguous, at least for past populations.
Relative to sex, studies of both living (e.g., Eyigor et al. 2015; Kraemer 2000) and past
(DeWitte 2010; 2017; Dewitte and Hughes-Morey 2012) populations have found that females,
regarding sex, and women, regarding gender, are generally more resistant to stressors and are
more likely to efficiently respond to stressors (i.e. less frail and more resilient) than males and
men (e.g., Morris-Prather et al. 1996; Samad et al. 2014). Further, studies of living populations
suggest that while females are more likely to have high frailty, they are less likely to have higher
mortality risk associated with high frailty than do males, demonstrating that females have higher
resilience (Eyigor et al. 2015).
Relationships between frailty and biological sex may be due to underlying physiological
processes, namely that females are more resilient and less frail due to elevated resilience in
response to the health costs of pregnancy and reproduction throughout human evolution
(Kraemer 2000; Read and Gorman 2010). Specifically, pregnancy has selected for resilient
females who can survive the stress of pregnancy and child birth reproduction (Kraemer 2000;
Read and Gorman 2010). Relationships between frailty and gender may be due to underlying
biosocial processes. Primarily, over time, the physiological impacts of gender-based
discrimination drove selection for physiologically resilient women with efficient and effective
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stress response systems that minimized physiological collateral damage (Krieger 1990). These
sex- and gender-based processes may also negatively synergize (e.g., Juster and Lupien 2012).
One of the most widely used interpretive frameworks for understanding how frailty
relates to negative environmental conditions in early-life is the Developmental Origin of Health
and Disease (DOHaD) paradigm. DOHaD proposes that poor or adverse environmental
conditions during growth and development in early-life (c. ≥18 years of age) can lead to
physiological dysregulation throughout life. This dysregulation increases the risk of poor health
outcomes during adulthood. These outcomes include early age-at-death as well as an increased
risk of chronic and degenerative conditions (e.g., Baird et al. 2017; Cornman et al. 2017;
Godfrey et al. 1994; McDade 2003; McDade et al. 2008). This relationship has been
demonstrated within both living populations (e.g., Bellis et al. 2015; Cohen et al. 2010; Evans
and Kim 2007; McEwen 2000) and archaeological skeletal samples from past populations (e.g.,
Boldsen 2007; Crespo et al. 2017; DeWitte 2017; Evans and Kim 2007; Goodman and
Armelagos 1989; Marklein et al. 2016; Watts 2015). In order to assess negative environmental
conditions during early-life (hereafter referred to as “early-life stress”) relative to frailty,
biomarkers in the Marklein and colleagues’ SFI that indicate growth disruption (e.g., LEH,
Femoral Length, Femoral Head Diameter) were used in isolation from the other biomarkers in
this study. However, since femoral metrics could not be collected in the skeletal sample used in
this study, only LEH is assessed here.
Resilience is a concept used in medicine as well as a diverse range of other fields, such as
economics and engineering that, as noted above, generally refers to resistance to, and recovery
from, stressors (Witham and Sayer 2015). Measures of resilience, which were originally
proposed by ecologists (Walker et al. 2004), assess the magnitude of stressors, the resistance of
5

the system, the threshold for change in the system, and the interrelatedness of the parts in a
system. In clinical practice, resilience is a quantification of the ability of a physiological system
to resist and recover from stressors without collapsing (DeWitte et al. 2017; Witham and Sayer
2015). Clinically, as well as within public health, resilience is studied in order to develop
interventions that can increase resilience in target populations (Witham and Sayer 2015). For
example, one measure of resistance is through assessing the strength of the immune system. The
immune system may subsequently be boosted through interventions such as vaccinations or
medications (Witham and Sayer 2015).
Importantly, frailty cannot be considered in isolation from resilience (Whitson et al.
2018). This is because the two variables are distinctly different from each other, yet tightly
related; an individual may have high frailty, for instance, but possess this trait because they have
high resilience, which enabled them to survive exposure to a great number of stressors (Witham
and Sayer 2015). Therefore, these two measures should be seen as complementary rather than
oppositional and must be investigated in tandem (Whitson et al. 2018). Specifically, the
physiological deficits measured in frailty indices cannot be considered without additionally
assessing resistance to and recovery from those stressors (Whitson et al. 2018).
Bioarchaeologists are increasingly focusing on assessing resilience in past populations, as well as
analyzing it relative to frailty (DeWitte et al. 2017). Skeletally, resilience, conceptualized as
recovery from or long-term (chronic) resistance to a stressor, can be measured based on evidence
of healing (Marklein et al. 2016). Evidence of healing signifies that the individual survived the
stressor(s) that induced the observed skeletal lesion, and recovered from it, at least to some
extent (DeWitte 2014). Alternatively, linear enamel hypoplasias seen in adult dentition signify
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survival of and recovery from the stressors that induced those lesions in childhood (Armelagos et
al. 2009; Goodman and Rose 1990).
When resilience is considered alongside frailty, as it is here, I propose that several of the
biomarkers in the SFI can be interpreted as having a dual meaning. Specifically, their presence
can be understood as both indicators of frailty, when summed in the SFI, but also as indicators of
resilience, when they exhibit evidence of healing. Accordingly, here healing indicates survival of
and recovery from a given stressor. In this way, both frailty and resilience can be assessed
simultaneously and relative to demographic factors that might affect these phenomena, such as
age and sex, as well as those related to other aspects of health, such as stress and early-life stress.
1.1.1

The MSA and the Skeletal Sample
The Mississippi State Asylum (MSA) was open from 1855 to 1935 and housed more than

35,000 patients over these 80 years, roughly 10,000 of whom died in the MSA (Davenport
2016). To date, 67 burials have been recovered from the potter’s field associated with the MSA.
These remains were recovered by, and are presently housed at, the Cobb Institute of Archaeology
(Cureton et al. 2014). This sample (n=67), which was analyzed in the present study, represents
individuals who were part of the asylum population during the early 20th century (Cureton et al.
2014) and died there between AD 1909 and 1930, based on dendrochronology dates from
associated coffin wood (Herrmann et al. 2016). Additionally, patients of the MSA are known to
have represented various regions within the state, socioeconomic classes, and social races
(Mississippi State Lunatic Asylum 1884; Mississippi State Lunatic Asylum 1888; Plemons
2016). This diversity translates to a skeletal sample that reflects assorted life experiences prior to
institutionalization.
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1.1.2 Modifying the Methodology
While the SFI is a highly flexible tool that can be used to address a wide variety of
research questions (Marklein et al. 2016), it has not yet been widely used in bioarchaeology.
Overall, published studies on the SFI have applied it to relatively large and well-preserved
skeletal samples. For instance, Marklein and colleagues (2016) applied the 13-biomarker-SFI to
134 complete skeletons from Medieval England. Siddiqui and colleagues (2019) applied a 9biomarker SFI to 428 skeletons from Himera, in Sicily. Even fewer studies address
methodological modifications to the SFI. For example, Gaddis and colleagues (2019) applied the
SFI to a small (N=36) sample and provided guidelines for modifying the SFI to weight
biomarkers along a scale, rather than simply by presence or absence. The study presented here
further explores the applicability and flexibility of the SFI by applying it to a relatively small
sample size (N=67) that is poorly preserved and heavily taphonomically damaged (see
Materials). It shows how, with some minor modifications, the SFI can produce valuable insights
into frailty and resilience for smaller, poorly preserved samples, such as that from the MSA.
1.1.3

Comparing Prevalence
In order to better understand frailty in the MSA sample, prevalence data for each of the

biomarkers were compared to published data (Coolidge 2016; de la Cova 2008; Gengo 2014;
Hunt and Bullen 2007) from analyses of the Robert J. Terry Anatomical Skeletal Collection
(hereafter referred to as the “Terry Collection”). This sample has a comparable temporal (i.e.,
roughly AD 1900-1950) and spatial context (i.e., the southern United States) to the MSA and, as
the above studies discuss, includes individuals who also faced systemic economic
disenfranchisement and race-based discrimination (see Background). As is discussed below,
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additional considerations for differences in analysis methods and demographics (e.g., age and
sex) between the two samples were made to facilitate these comparisons.
1.2

Research Goals & Questions
This thesis has two main research goals. First, this study provides a template for

modifying the SFI for future research. The SFI was developed to be adaptable to a wide variety
of research questions and skeletal samples (Marklein and Crews 2017; Marklein et al. 2016).
However, some additional parameters (e.g., minimum sample sizes, preservation conditions,
creation of multiple frailty indices) should be developed in order to maintain comparability
between different studies that use the SFI. Therefore, throughout this study various modifications
have been made to the SFI and areas for further modification are discussed. First, several of the
original 13 biomarkers were not assessed in this study. Fractures (e.g., trauma) were excluded, as
were biomarkers that could not be observed in the MSA sample, largely due to its poor
preservation (e.g., femoral length, femoral head diameter, osteoporosis). Second, the decreased
likelihood of observing biomarkers in incomplete skeletal material has been corrected for
statistically. Finally, the modifications made in this study maximize the sample size available for
analysis by dividing out the original 13-biomarker-SFI developed by Marklein et al. (2016) into
several smaller indices (e.g., Nutrition SFI) that focus on particular categories of stress and
frailty (e.g., nutritional frailty).
Second, this study investigates the relationships between frailty, resilience, age, sex, and
early-life stress in a skeletal sample (N=67) from the MSA. Within this goal, three primary
research questions are proposed. First, given established age-based variation in frailty in both
living and past populations, is age-based variation in frailty present in the MSA sample? Second,
given established sex-based differences in resistance to and resilience from stressors (Glei et al.
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2013; Griffin et al. 2018; Guatelli-Steinberg and Lukacs 1999), and gender divisions within the
Asylum (e.g., separate wards and labor tasks) (Barringer 2016) and contemporary society in
Mississippi (see Background), is sex- and/ or gender-based variation in frailty present in the
MSA sample? Finally, given the established relationship between early-life stress and adult
health outcomes, is variation in frailty associated with early-life stress experiences (i.e. LEH) in
the MSA sample? Each of these questions has several sub-questions, which are outlined below.
Two supplemental questions are investigated as well regarding resilience and comparison of the
MSA to the Terry Collection.
To address these questions, multiple frailty indices (i.e. Overall SFI, Nutrition SFI, Infection
SFI, Activity SFI) were used, in addition to crude prevalence of each biomarker. As noted above,
the original 13-biomarker-SFI developed by Marklein and colleagues (2016) was parsed out so
that correlations between different biomarkers, specifically between the biomarker that indicates
early-life stress (i.e. LEH) and those that reflect adult health experiences (e.g., osteoarthritis),
could be assessed. Each of the indices (i.e. Overall SFI, Nutrition SFI, Infection SFI, Activity
SFI) and the prevalence of each biomarker were analyzed in relation to sex, age, early-life stress,
and resilience and were assessed relative to the Terry Collection. Finally, data on the status of
several of the biomarkers (e.g., active, healing, healed) was used to assess resilience.
1.

Does a correlation exist between frailty, measured via each SFI, and age at death?
a. If a correlation exists, is this relationship inverse (e.g., do older age
categories have consistently lower skeletal frailty indices than younger age
categories)?
b. If a correlation exists, which specific biomarker(s) (presence) correlates
most closely with age at death? In other words, which biomarker(s) best
accounts for the relationship between each SFI and age at death?
c. If a significant correlation exists, is this correlation stronger for one sex
(male/female)?
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d. Is the frequency of early-life stress biomarkers (i.e. LEH) consistent
through the age categories?
2.

Does a correlation exist between frailty, measured via each SFI, and sex?
a. If a correlation exists, does one sex have consistently higher SFIs?
b. If a correlation exists, which specific biomarkers explain the greatest
variance between sexes?
c. Is the frequency of LEH higher for one sex (male/female)?

3.

Does a correlation exist between evidence of early-life stress (i.e. LEH) and
frailty in adulthood?
a. If a relationship exists, is a specific biomarker (or combination of
biomarkers) most correlated with evidence of early-life stress(i.e. LEH)?
b. If a relationship exists, is a specific early-life stress indicator (LEH) most
correlated with high SFIs?

1.3

4.

How does resilience, measured through evidence of healing, relate to age, sex,
early-life stress (i.e. LEH), and frailty, measured via each SFI?

5.

Based on published data from the Terry Collection (Coolidge 2016; de la Cova
2008; Gengo 2014; Hunt and Bullen 2007) how does frailty, specifically the
prevalence of each biomarker in the MSA, compare to that in the Terry
Collection?

Theoretical Frameworks
The research questions posited here require overlapping two interpretive frameworks to

facilitate holistic data analysis and interpretation. These are the biocultural approach and
ecosocial theory. The biocultural approach “explicitly emphasizes the dynamic interaction
between humans and their larger social, cultural, and physical environments” and views human
variation as an adaptive strategy that is produced in part via interactions with the environment
(Zuckerman and Armelagos 2011: 13). Its use in bioarchaeology is in part premised on the idea
that the material human body is produced and reproduced by culture and the environment, which
in turn interact with each other (Zuckerman and Armelagos 2011; Zuckerman et al. 2012). This
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approach is used to interpret frailty and resilience as adaptive strategies that are either aided or
impeded by living conditions, both during and prior to institutionalization for patients in the
MSA.
Ecosocial theory synthesizes biological, environmental, and social aspects of health
within a context-specific framework that views these elements as working synergistically in the
embodiment of health experiences (Krieger 1994; 2001; 2011). Specifically, it proposes that
social and economic inequalities beget health inequalities, following the idea that human bodies
incorporate or embody their biological, social, and physical conditions. Additionally, Ecosocial
theory situates health in a historical context by demanding that the historical events and
processes that laid the groundwork for health inequalities are fully considered in analyses of
present-day populations (Krieger 1994). This integrated view of health helps to frame the ways
in which social dynamics, both past and present, shape disease experiences alongside biological
mechanisms, such as genetics (Krieger 2001; 2012). Interpreted through the lens of ecosocial
theory, markers of stress, disease, and trauma on the skeleton, including the biomarkers in the
SFI, may signal not only what has happened biologically within an individual’s body, but also
what that individual, and more broadly the population to which that individual belonged, was
exposed to as a product of their environments.
As is discussed further in the Background, social race, poverty, and race-based
discrimination are particularly relevant to analyses of the MSA. Specifically, for individuals in
the MSA sample, markers on their skeletons may signal their individual experiences during their
early-life, in the period generally prior to their institutionalization, as well as in their later life, at
least some part of which occurred during their institutionalization in the MSA (see Background).
The ‘Negro’ or ‘Colored’ patients at the MSA faced a particular set of biosocial conditions in
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early-life and during adulthood, prior to their institutionalization. Prior to institutionalization,
they would have lived in segregated and largely impoverished to lower and laboring class
communities in Mississippi and faced racial discrimination and violence in the Deep South
during the Civil War, Reconstruction, and post-Reconstruction, particularly with the rise of Jim
Crow laws (Barringer 2016). “White” patients at the MSA also experienced stressful biosocial
conditions prior to institutionalization. While some white patients at the MSA were upper to
middle class (Gibson, personal communication, 2019), most were of poor and lower to laboring
class backgrounds. Although they would not have faced race-based discrimination and
segregation outside or inside the MSA, like their ‘Negro’ peers at the MSA did, poor whites
during this time would have faced economic disenfranchisement and instability, faced poor
living conditions, and been barred from upward mobility throughout the Deep South (Flynt 1989;
Koger 2012).
Here, the use of ecosocial theory therefore frames the findings of this study both
historically and epidemiologically. Ecosocial theory posits that health is the embodiment of
environmental, social, and biological influences. In this view, exposure, resistance, and
susceptibility to disease are not merely defined within the bounds of physiology. Rather,
exposure, resistance, and susceptibility result from a synergistic interaction between multivariate,
often non-biological, influences such as poverty and racism. Thus, numerous and diverse
potential influences on health are considered in tandem in this study to explain the patterns of
frailty relative to age, sex, early-life stress, and resilience uncovered by this study. Here,
ecosocial theory provides a framework for understanding pathways to embodiment over the life
course on a multilevel scale (e.g., individual, regional, national) that is historically
contextualized.
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CHAPTER II
BACKGROUND
2.1

Defining and Operationalizing Health
There are two main obstacles to understanding patterns of health: defining health and

operationalizing definitions of health (Huber et al. 2011; Schulkin 2004). In 1948, the WHO
defined health as “a state of complete physical well-being and not merely the absence of disease
or infirmity” (WHO 1948). However, criticism of this definition has been mounting (Bircher
2005; Huber et al. 2011; Huber et al. 2016; McCartney et al. 2019; Stucki et al. 2018). First,
‘complete’ health sets an unrealistically high standard for health in which any abnormality, no
matter how small, can make someone unhealthy. Second, due to the rising incidence of chronic
and degenerative diseases in recent decades, an increasing number of individuals do not meet the
WHO definition of health (Huber et al. 2011). However, these individuals are still alive and
therefore still maintain some resilience. Therefore, a definition of physical health that focuses on
the maintenance of homeostasis (i.e. allostasis) and resilience is more inclusive and holistic
(Huber et al. 2011; Schulkin 2004). This study adopts a definition from Huber and colleagues
(2011), which defines health as the ability to maintain physiological homeostasis in the face of
stressors through effective protection and stress responses. Using this definition, health as
evidenced skeletally is not simply the absence of skeletal lesions. Rather, health is evidenced by
recovery from stressors – resilience – evidenced via healing with considerations for age at death.
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2.2

Physiological Stress Responses to Chronic and/or Episodic Stressors
Throughout the life course, all organisms are exposed to environmental stressors that

ignite stress responses that can impact both long and short-term health (Oken et al. 2015). Thus,
as discussed above, scholars have argued that health should not merely be considered the
absence of disease or stress (Huber et al. 2011). Rather, as the definition of health used in this
study states, health includes the ability to maintain homeostasis when exposed to stressors in the
surrounding environment (Huber et al. 2011). The environment can be defined as all external
influences including, but not limited to, pathogen exposure, social and physical conditions
associated with socioeconomic status, air/water quality, and nutritional status (Arthur et al.
2016). While this definition is broad, it suits this research given that this study in part seeks to
holistically understand health experiences over the life course, rather than specific making
diagnoses in the skeletal sample of the MSA. Additionally, the cultural environment can both
buffer individuals from stressors and exacerbate and increase their exposure to stressors
(Goodman and Armelagos 1989). When stressors cannot be avoided or buffered, organisms
experience stress and mount a response (Johnson et al. 1992).
Stress is the physiological response to stressors that amplifies fight-or-flight response
mechanisms in the short term to decrease physiological damage and restore homeostasis
(Johnson et al. 1992). The three-stage process of the stress response is known as general
adaptation syndrome (Selye 1936). First, stressors trigger an alarm response that activates the
somatic nervous system, increasing blood pressure, and prompting the release of various stress
hormones (e.g., cortisol, glucocorticoids, catecholamines), which break down glucose and
proteins to power the immune response (McEwen 2000). Then, after the stressor ends, normal
physiological functions are restored, but high hormone levels are maintained. In most cases,
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homeostasis is achieved when hormone levels return to normal. While short-term (acute) stress
responses are beneficial, long-term (chronic) or episodic chronic responses are physiologically
damaging (Dabhar and McEwen 1996; Hoffman et al. 2017; Selye 1936). In cases when
exposure to the stressor is episodic or chronic, the stress response can exhaust the body’s
resources, increasing the individual’s susceptibility to infections and non-communicable disease,
and damaging physiological systems (i.e. cardiovascular). In growing and developing
individuals, it can also arrest and reduce growth and development. Chronic and/ or episodic
stress responses can also cause chemical imbalances, rhythm dysregulation, and neural atrophy
(Flinn 2006; Hoffman et al. 2017; McEwen 2000; Selye 1936; Ygberg and Nilsson 2011).
Therefore, chronic and/or episodic stress responses can increase both morbidity and mortality
(Flinn 2006).
2.3

The Utility of Frailty Indices
In order for definitions of health to have meaning, they must be able to be operationalized

(Huber et al. 2011). This is most efficiently done when existing measures for assessing an
individual’s ability to maintain homeostasis (e.g., physical activity capacity, difficulty of daily
activities) can be used (Huber et al. 2011; Van Weel 1993). Additionally, health must be
simultaneously understood on both an individual-level and a population-level (Huber et al.
2011). For example, a single individual’s health (e.g., the presence of cardiovascular disease) can
be assessed or data from many individuals (e.g., a sample) can be aggregated to estimate
population-level health (e.g., the prevalence of cardiovascular disease). However, this can be
problematic. That is because individual- level measures of health cannot be generalized to
populations and sample-wide measures of health tend to homogenize individuals.
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Instead, frailty indices can provide a systematic way to simultaneously assess both
individual- and population-level experiences of health. They do so by providing measures of
both individual-level frailty and population-level patterns of frailty, rather than simply crude
prevalence data (Marklein et al. 2016; Xue 2011). The biomarkers incorporated into frailty
indices for living individuals, such as weakness and physiological systems functioning (e.g.,
cardiovascular)(Cornman et al. 2017), can also be analyzed independently for crude prevalence
as well as for associations with demographic factors, such as age and sex. Additionally, these
indices are often applied to geriatric and surgical samples in order to assess the morbidity and
mortality risk of various health interventions (Binru et al. 2019; Burn et al. 2018). In some cases
they have also been used to study the cumulative health effects of social and income inequality
(Hoogendijk et al. 2018).
While frailty indices provide a functional and flexible way to operationalize ‘health’, a
single definition of frailty has not been agreed upon, as is noted in the Introduction (Varadhan
and Buta 2015). Some researchers view frailty as physiological vulnerability to stressors while
others view it as homeostatic dysregulation (Varadhan and Buta 2015). Cumulatively, these
definitions associate frailty with decreased capacity to withstand stress and a lack of
physiological complexity, interconnectedness, feedback, redundancy, and energy flow (Varadhan
and Buta 2015). It should be noted however, that frailty, while correlated with morbidity and
mortality, is not a direct measure of the risk of morbidity and mortality (Cornman et al. 2017).
Accordingly, for the purposes of this study, frailty is understood to be a measure of accumulated
or layered deficits in physiological functioning across physiological systems that tends to
increase with age (Cornman et al. 2017).
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The ability of frailty indices to provide insights into population-level patterns of health
experiences in past populations addresses a main concern of the osteological paradox:
heterogeneous frailty (Wood et al. 1992). This refers to the fact that in any population,
individuals have varying levels of frailty and risk of morbidity and/ or mortality. For example,
individuals who had early-life experiences of stress, such as those manifesting LEH, may be be
more frail when compared to their peers who did not face these stressors in early-life (Bellis et
al. 2015; Haapanen et al. 2018). When data from these individuals is aggregated however (e.g.,
calculating crude prevalence of a biomarker), in order to understand population-level patterns of
health, meaningful information about these individual-level experiences is lost. Metaphorically,
aggregate-level data highlights the forest but overlooks the trees. Alternatively, if individuallevel data are not aggregated, the data show individual trees but not the forest. Therefore, a a
multi-scalar approach in bioarchaeology that simultaneously highlights both the trees (e.g.,
variation in frailty between individuals) and the forest (e.g., aggregate data regarding population
patterns of frailty) is needed in order to more holistically understand population-level health
experiences in the past. This need is met by the SFI, which addresses heterogeneous frailty
through research design (Marklein et al. 2016), rather than through post-hoc analysis.
2.4

The Skeletal Frailty Index
The strengths of the SFI are its flexibility and its applicability to a wide range of samples

and research questions, but it does have some methodological shortcomings. As noted above, the
original SFI included 13 biomarkers, but it also functions effectively when fewer are used
(Marklein et al. 2017). This flexibility allows researchers to investigate specific types of frailty.
For instance, mobility related frailty could be investigated using a 3-biomarker-SFI that includes
OA, RCD, and IVD. It also allows the SFI to be operationalized when the presence or absence of
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all 13 biomarkers cannot be observed due to poor or partial preservation of the remains. For
instance, when dentition is absent across a sample and LEH cannot be assessed, LEH can be
removed from the SFI. Problematically though, the SFI’s cumulative measure is based only on
‘presence’/’absence’ scoring. This means that all of the biomarkers are equally weighted. For
instance, the presence of multiple periosteal reactions within an individual generates the same
score (1) for that biomarker as does the presence of just one periosteal lesion (1). Therefore, the
duration of the stressor(s), the number of times the stressor(s) was experienced, the relative
strength of the stressor(s), and the status of the stressor(s) at time of death (e.g., ongoing or
resolved) are not incorporated into the SFI. Because of this, the SFI considers the breadth of
frailty for each individual (e.g., the number of different conditions present), but does not consider
the depth (e.g., severity, number of occurrences) of frailty. Exclusively using
‘presence’/’absence’ scoring also means that the SFI alone cannot be used to investigate
resilience, which is a major impediment to contextualizing the frailty relative to age-at-death.
2.5

Considering Resilience
Measuring resilience is, unsurprisingly, complex. Measures of resilience in modern

populations often consider the magnitude of a stressor, and the physiological impact of that
stressor, which include the likelihood of the stressor causing permanent damage to or
dysregulation of physiological systems (e.g., the immune response). They also often consider the
interconnectedness of the system affected by the stressor—which could be any physiological
system—with other physiological systems (e.g., the interaction between the immune and
lymphatic systems) in the body. Witham and Sayer (2015: 101) classify these measures into four
categories. These include latitude, which is “the magnitude of the stressor and any change to
biopsychosocial function”, and resistance, which is “how much biopsychosocial function
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changes under the impact of a stressor and the rate of recovery.” They also include
precariousness, which is “whether the stressor leads to a permanent change in function,” and
panarchy, which is “how an effect on one system translates to an effect on other systems”.
In bioarchaeology, considering resilience in tandem to frailty fundamentally addresses
the osteological paradox (Wood et al. 1992). Importantly, resilience can be used to explain the
proximate causes of heterogeneous frailty, (e.g., high frailty may be due to high resilience), and
selective mortality, in which the frailest individuals in each age cohort have the highest mortality
risk (DeWitte 2014; DeWitte 2017; DeWitte et al. 2016; Wood et al. 1992; Yaussy et al. 2016).
Specifically, it can be used to explain how individuals with low resilience relative to their age
cohort have higher mortality risk (e.g., DeWitte 2014). However, the four categories used in
clinical studies to assess resilience in modern populations (i.e. latitude, resistance,
precariousness, panarchy), cannot be directly investigated via skeletal remains. In particular, the
stressors, rate of recovery, and the lasting psychological and social impacts of the stressors
cannot be observed skeletally. Using skeletal lesions and clinical literature however, it is possible
to assess precariousness and panarchy to some extent in the skeleton. This is because measures
of precariousness and panarchy are evidenced skeletally via healed lesions. Healing indicates
that the stressor, or at least the stress response to the stressor, was not ongoing at the time of
death. For instance, individuals with ‘healing’ or ‘healed’ periosteal reactions at time of death
have a survival advantage relative to individuals with ‘active’ reactions (Berger and Wang 2017;
DeWitte 2014). Additionally, O’Donnell (2019) finds that active PH and CO lesions are
associated with a higher mortality risk than healed lesions. While some studies have shown that
evidence of early-life stress (e.g., LEH) can be used as a proxy for resilience in adults (Hoover
and Hudson 2016), this study is additionally interested in the relationship between early-life
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stress and resilience in adulthood. In other words, do individuals with LEH have an advantage
because they were resilient in childhood or has physiological dysregulation caused by early-life
stress reduced their capacity for resilience? Therefore, to avoid ‘double-dipping’, LEH is not
used as a proxy for resilience here. In this study, resilience is indicated when healing, ongoing or
complete, is present. Specifically, this study this includes evidence of healing for periosteal
reactions, PD, PH, and antemortem tooth loss (AMTL). While other biomarkers could have been
included, such biomarkers either were excluded from this study entirely (e.g., femoral metrics,
fractures) or ‘healing’ of these skeletal lesions is not common or cannot be observed
macroscopically (e.g., osteoporosis, osteoarthritis, IVD, RCD, rickets/osteomalacia).
2.6

Developmental Origins of Health and Disease
The DOHaD paradigm proposes a link between early-life stress, occurring before 18

years of age, and immunological and physiological shifts that are related to poor health outcomes
in adulthood (Baird et al. 2017; Cornman et al. 2017; Godfrey et al. 1994; McDade 2003;
McDade et al. 2008). Overall, these studies suggest that stress, especially early-life stress,
produces a body that is physiologically unprepared to effectively respond to stressors later in life,
during adolescence and adulthood. Further, the adult body can be immunocompromised due to
stress-induced immunological dysregulation. Together, these processes lead to an increased
susceptibility to pathogens and chronic infectious diseases and chronic and degenerative
conditions, as well as increased frailty (Ygberg and Nilsson 2011).
Biologically, the relationship between early-life stress and adult health experiences is
ultimately a consequence of chronic and/ or episodic stress responses. In modern populations,
individuals who experience chronic early-life stressors or adverse childhood experiences (ACEs)
before 10 years of age are twice as likely to experience serious illness during adolescence and
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young adulthood (Power and Peckham 1990; Wadsworth 1991). Early-life stressors that are
proven to correlate with adverse health consequences later in life include abuse, neglect, low
socioeconomic status, poor air/water/nutritional quality, toxic element exposure, family
dysfunction, as well as parental addiction, incarceration, separation, and poor mental health
(Bellis et al. 2015; Cohen et al. 2010; Holladay and Smialowicz 2000; McEwen 2000). Adult
health impacts known to correlate with these early-life stressors include language impairments,
hyperactivity, aggression, decreased physical activity, cellular damage, physiological
dysregulation, and increased susceptibility to pathogens (Cohen et al. 2010). These impacts make
adults more susceptible to both acute and chronic illness. While little is known about which
ACEs relate to specific aspects of adult health, the link between early-life stress and poor adult
health is undeniable (Cohen et al. 2010). Biological, epigenetic, and social factors, as well as
intergenerational effects, interplay to produce this association within the individual body (Baird
et al. 2017; Bellis et al. 2015; Hoffman et al. 2017; Mulligan 2016).
Given that the relationship between stressors and the physiological stress response that
they trigger is complex, several models have been used to explicate the relationship between
early-life stress and adult health experiences (Cohen et al. 2010). Each model outlines different
aspects of the relationship between stress responses and physiological consequences of chronic
or episodic stress. The three models surveyed here focus on the impact of environmental
influences, specifically stressors, early in life on overall health and frailty in adulthood.
First, the timing model posits that the impact of a stressor will vary based on the type of
stress experienced and the period in development during which the stressor occurs. For example,
psychological stressors have the greatest long-term impact when experienced in the second half
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of early-life (e.g., adolescence), while physical stressors will have the greatest long-term impact
when experienced during the first half of early-life (e.g., weaning) (Cohen et al. 2010).
Second, the accumulation model states that both stressors and their consequent
detrimental effects accumulate throughout the life course, producing increased frailty and an
increased inability to respond to stress (e.g., decreased resilience) with age (Cohen et al. 2010).
In this model, the ‘total dosage’ of exposure is prioritized while the age of onset is irrelevant.
Finally, the change model predicts that upward socioeconomic mobility from childhood
to adulthood will increase access to better nutrition and health care, thus leading to more positive
health outcomes (Cohen et al. 2010). The reverse of this model posits that the relationship
between early-life stress and negative health outcomes in adulthood occurs because the stressor
continues through life, chronically and/ or episodically (Cohen et al. 2010).
Additionally, stressors experienced during fetal development and into infancy may cause
epigenetic changes (Ygberg and Nilsson 2011) that may increase an individual’s vulnerability to
poor health throughout life. These epigenetic changes occur, in part, due to a phenomenon
known as the ‘thrifty phenotype’, in which phenotypic changes occur due to a change in the
environment that encourages adaptation for survival as part of the predictive adaptive response
(Hales and Barker 2001).
Due to impaired physiological development associated with experiences of early-life
stress, those with evidence of early-life stress are more likely to be frail in adulthood, therefore
increasing their morbidity and mortality (Holladay and Smialowicz 2000; Watts 2015; Ygberg
and Nilsson 2011). Impaired physiological development resulting from early-life stress lessens
an individual’s ability to appropriately respond to stressors (Holladay and Smialowicz 2000;
Watts 2015; Ygberg and Nilsson 2011). Therefore, individuals with early-life stressors are more
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likely to have increased frailty and decreased resilience. While these phenotypic changes may be
unlikely to evidence themselves skeletally, the long-term impacts of these epigenetic shifts, such
as resting cortisol levels, ability to uptake nutrients, and immune response regulation, may
produce effects that are evidenced skeletally (Klaus 2014).
Indeed, the DOHaD paradigm has also been supported by studies of past populations
(e.g., Armelagos et al. 2009; Bellis et al. 2015; Coolidge 2016; Goodman and Armelagos 1988;
Power and Peckham 1990; Turner et al. 2016). These build upon the long-standing practice in
bioarchaeology of interpreting evidence of early-life stress through oral and skeletal stress
indicators, such as LEH, stunting, or narrowing of the neural canal (Clark et al. 1985). In this
study, only LEH was assessed to identify instances of early-life stress. This is because stunting,
which is identified based on reduced femoral length and reduced femoral head diameter in the
original SFI, could not be assessed in the MSA sample due to poor preservation.
2.7

Age, Sex, and Frailty
As will be outlined in the following sections, age and sex have known associations with

frailty. As highlighted by Yaussy (2019), considering intersectionality - the multiplying
interactions of oppressions - is vital to interpreting variation in skeletal indicators. In order to
best assess the relationship between early-life stress and frailty, these confounding variables
must be understood and adjusted for.
2.7.1

Age Variation in Frailty
In modern populations, studies have found that mortality is better predicted by frailty

than by age (Arya et al. 2015; Rockwood and Howlett 2019; Romero-Ortuno and Kenny 2012).
Specifically, individuals with the highest frailty within their age categories often have the highest
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morbidity and mortality (Barker and Osmond 1986; Hoffman et al. 2017; Wadsworth 1991). In
other words, individuals who are young and frail are just as likely to die as individuals who are
old and frail. However, that is not to say that the risk of high frailty is consistent across age
groups. In fact, a review of the published literature suggests that the risk of high frailty across
age groups (e.g., young adulthood through geriatric) has not been assessed in the clinical
literature. Most studies target geriatric populations, defined as individuals 65 and older, for
longitudinal studies of frailty (e.g., Binru et al. 2019; Burn et al. 2018; Haapanen et al. 2018;
Hoogendijk et al. 2018). So, while frailty is known to be more common in older age groups
(Gale et al. 2014), the risk of high frailty across age groups is not currently well understood.
Although the relationship between age-at-daeth and frailty has been assessed across age
groups in bioarchaeology, the findings are contradictory. Some have found that frailty increases
with age as exposure to stressors accumulates (Marklein and Crews 2017), while other studies
find that the frailest individuals die young, therefore associating high frailty with younger age
categories (DeWitte 2010; DeWitte 2017; DeWitte and Bekvalac 2010; Wood et al. 1992).
Marklein and colleagues (2016) acknowledge that this discrepancy may be the result of
environmental differences. In more stressful environments, frail individuals die young while in
populations experiencing fewer, or less severe, stressors frailty accumulates with age. Furthering
this argument, other studies have found that sex and socioeconomic status are associated with
age at death (Yaussy 2019), suggesting higher SES does not decrease female mortality risk in the
same way it decreases mortality risk in males. In these studies, researchers are partially
addressing one of the primary issues posed by the osteological paradox (Wood et al. 1992): will
the frailest individuals survive stressors long enough for skeletal lesions to develop? If not,
frailty should be expected to increase with age, as older individuals survive long enough for
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skeletal lesions to manifest.
2.7.2

Sex Variation in Frailty
Studies of modern populations demonstrate that relative to sex, females are likely to meet

more categorical qualifications of frailty (e.g., a higher frailty index), but are less likely to have
high mortality rates associated with high frailty scores (Eyigor et al. 2015; Gordon et al. 2017).
Additionally, while females in modern populations are likely to have higher frailty in old age,
they are less likely to die as a result of higher frailty (e.g., greater resilience) (Eyigor et al. 2015).
This phenomenon, in which females have higher frailty but live longer, is referred to as the
female-male health-survival paradox (Wingard 1984). It can be explained by evolutionary and
societal differences related to sex and gender. Specifically, females are known to resist and
respond to stressors more efficiently than do males due to the development of physiological
mechanisms used to cope with the demands of reproduction. Furthermore, women resist and
respond to stressors more efficiently than do men due to the development of physiological
mechanisms for coping with gender-based inequality (Kraemer 2000). Additionaly, Juster and
Lupien (2012) find that individuals with greater masculinity performance, both male and female,
have a higher allostatic load (i.e., frailty) than individuals who have a greater feminine
performance.
High resilience in females is also supported by bioarchaeological findings (DeWitte
2010; DeWitte 2017; Gamble et al. 2017). For instance, DeWitte (2017) found that females
better resisted and recovered from the Black Death, potentially due to physiological sex
differences (e.g., immune system efficiency), differential access to nutritious foods, or variation
in pubertal timing. However, some studies produced contradictory results. For example, in a
sample of famine and attritional burials from 12th to 16th century London, Yaussy and colleagues
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(2016) found evidence of higher mortality in females despite a higher prevalence of periosteal
reactions in males, potentially due, in part, to differences in working conditions (Yaussy 2019).
This may suggest that females were not exposed to the same stressors as males, were exposed to
the same stressors but were able to efficiently respond before periosteal lesions formed, or that
females were less resilient, leading to death prior to lesion formation. Further, DeWitte’s (2019)
findings do not support the male-female health-survival paradox relative to periodontal disease in
medieval period London. This may suggest that the female survival advantage outlined by the
male-female health-survival paradox may not be as applicable in non-contemporary, nonWestern societies. Alternatively, this may suggest that the male-female health-survival paradox
is, in part, negated in the absence of public health crises, such as epidemics. Given the
conflicting findings regarding female resilience in the bioarchaeological record, additional
investigations with large samples which are heavily contextualized are needed.
2.8

Historical Context – Biosocial conditions impacting stress, frailty, and resilience in
individuals in the MSA sample
Given that health is not an isolated experience but rather occurs over the entire life

course, including fetal development, the historical context that these individuals were born into
and lived through prior to their admittance into the MSA must be understood. In the Deep South,
the period from 1860 to 1935 was characterized by many periods of change and instability.
Transitions from slavery to freedom drastically affected the economy, the labor market,
migration, and the social order (Flynt 1989; Koger 2012). Prior to the Civil war, the Deep South
was a highly stratified and segregated society. At the top was the planter class, a wealthy elite
made up of white planters with large tracts of land. Yeomen, the white middle-class, owned
smaller amounts of agricultural land, and while their political power was legally equal to elites,
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their economic power was significantly reduced (Flynt 1989). Lower class whites, who did not
own agricultural land, were also in economic competition with the labor produced by the
enslaved persons owned by the planter class and Yeomen (Flynt 1989). African Americans who
were free born often owned property, including land, businesses, and enslaved persons (Flynt
1989; Koger 2012). Yeomen, poor whites, free born African Americans, and enslaved persons
were all marginalized to various degrees by the elites, leading to restricted to minimal access to
jobs, land, social capital, and individual agency (Flynt 1989).
Social and economic stratification in the Antebellum South also produced significant
health inequalities. The planter class had notably better health, such as lower rates of infectious
disease, and a better diet, than did the other classes (Seeman 2011), particularly compared to
African Americans, both enslaved and free. Yeomen relied on a subsistence-first diet and sold
the surplus (Billings et al. 2013), allowing them a typically more nutritious diet. Poor whites,
however, did not have land upon which they could farm for their own subsistence. This led them
to rely on the black market trade of goods between slaves and poor whites, which forced them to
rely on an unstable and often limited diet (Ott 2019). While skeletal evidence suggests that both
free and enslaved African Americans had poor health (e.g., high activity loads, a high prevalence
of infectious diseases), health experiences between these two groups differed. First, free African
Americans had lower activity levels (Steckel and Rose 2002) and lower levels of early-life stress,
than did whites, as evidenced by similar to greater stature, according to contemporaneous stature
records (Bodenhorn 1999). Second, and more surprisingly, enslaved African Americans were
better nourished than were the whites, based on analyses of zooarchaeological remains from
plantations (Reitz et al. 1985). However, enslaved persons in particular faced harsh living
conditions, including overcrowding, poor ventilation and insufficient insulation, leading to high
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rates of contagious diseases, such as typhus, tuberculosis, scarlet fever, and ringworm (Savitt
1981). They also experienced high rates of early-life stress, evidenced via LEH (Blakey et al.
1994), dental pathologies, and non-communicable diseases (Follett 2010). Of course, health
experiences within each of these classes were not homogenous and were known to vary by
region (e.g., urban, rural) (Margo and Steckel 1983), age (Steckel 1986), birth cohort (Margo and
Steckel 1983), sex, and labor/occupation (Margo and Steckel 1983) during this time period.
Following the Civil War, during the Reconstruction period (1865-1877) the quality of life
for the marginalized classes in the Deep South, specifically African Americans, decreased
(Carson 2009; de la Cova 2011; Meeker 1976; Rose 1989). For instance, the diet for poor whites
and both previously free and newly emancipated African Americans became primarily composed
of corn, pork, and molasses, which increased the likelihood of developing nutritional diseases,
such as pellagra and iron-deficiency anemia (Savitt and Young 1988). High property taxes
discouraged the purchase and ownership of land by anyone other than members of the planter
class, leading to the rise of sharecropping and tenant farming, producing economic-based
discrimination and inequality. Additionally, African Americans faced discrimination and
persecution at the hands of the Ku Klux Klan and Jim Crow laws . These stressors (e.g., racial
and economic discrimination, inequality, and disenfranchisement) are known to cause adverse
physiological responses, such as high blood pressure (Harrell et al. 2003).
Additionally, African Americans continued to experience highly limited access to
effective medical resources, resulting in overall poor health. This was, however, partially
ameliorated when the Bureau of Refugees, Freedmen, and Abandoned Lands opened hospitals
and coordinated home health visits for freed African Americans in order to fill this gap (Hasson
1982). Additionally, during this period many southern states established public welfare programs
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targeting healthcare, education, and the care of orphans and those with disabilities (e.g., the deaf,
blind, and ‘insane’) (Franklin 1970). While these programs likely aided African American
health, they did not completely mitigate the physiological harm caused by long term exposure to
stressors, both physical and psychosocial.
Immediately following Reconstruction, came the era of Jim Crow laws. During this time
population mortality patterns began to shift in the South (Haines 1994), signaling the start of the
second epidemiologic transition. This transition was induced by improvements in public health
efforts and was marked by changes in the mortality distribution (e.g., longer life spans on
average), decreasing death from infectious disease (e.g., tuberculosis), and rising mortality
caused by non-communicable diseases (Omran 2005). Therefore, pre- and post-second
epidemiologic transition rates of infectious, chronic, and non-communicable disease are starkly
different when compared. However, this shift was delayed more than 20 years in African
American populations due to systemic racism, discrimination, and violence (Haines 1994). For
instance, a study of North Carolina census records investigating mortality rates in whites,
‘mixed-race’ individuals, and ‘non-mixed race’ individuals between June 1879 and May 1880
found that mortality was twice as high in African American men than in white men (Green and
Hamilton 2013). Furthermore, the 1880 census shows the highest mortality rates for African
Americans in over three decades when compared to the three previous censuses, suggesting that
the onset of the second epidemiologic transition in white communities came at the expense of
African American health (Meeker 1976). In contrast, the same censuses found that mortality was
declining in white populations. In addition to active discrimination and violence suffered at the
hands of white southerners, African American’s health and survival was no longer to the
economic benefit of white southern society (Meeker 1976).
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2.9

Mississippi State Asylum
The MSA was opened in 1855 in Jackson, MS in association with a growing national

movement toward large scale health care and welfare services (e.g., orphanages, asylums, public
hospitals, institutes for the blind and deaf) (Franklin 1970). The asylum movement in the United
States resulted in large part from the advocacy work of Dorothea Dix, who traveled the United
States helping to open and improve state asylums (Gollaher 1993). In fact, her visit to
Mississippi accelerated the approval and opening of the MSA. When it opened, the MSA’s
mission was also congruent with the larger national movement’s aim of providing ‘moral
treatment’ (e.g., psychological, mental treatment) (Charland 2012). Moral treatment was a form
of rehabilitation that focused on balancing work and leisure, in a quiet rural environment with
highly structured social interactions. In keeping with this, the MSA was built to provide an
environment of benevolent paternalism (i.e., limiting patient autonomy as a father would limit
their child’s autonomy) (Charland 2012) focused on treating the mentally and chronically ill
(Barringer 2016).
The MSA was also, at least in its early years, primarily intended to provide this service to
Mississippians from a range of backgrounds. The demographic makeup of MSA patients was
diverse. Patients ranged in age from under 15 years old to over 70 years old. Biennial reports
from the MSA document the admission of patients from every county in Mississippi, as well as
many other states, and countries from across Europe (Mississippi State Asylum 1884;
Mississippi State Asylum 1888). The occupations of admitted patients are also varied (e.g.,
farmers, housewives, teachers, physicians, seamstresses, lawyers, druggists) and span the social
classes (e.g., farmer’s wives vs. housewives). Patients were also institutionalized for a variety of
reasons, including chronic illnesses (e.g., epilepsy), mental illnesses (e.g., chronic, acute,
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epileptic, periodical, and hysterical mania; dementia), and other issues (e.g., domestic troubles),
with a variety of attributed causes (e.g., heredity, religion, intemperance, uterine affection, blows
to the head).
Over time, financial struggles and overcrowding began to present obstacles to high
quality care, treatment, and rehabilitation for these patients (Barringer 2016). As an increasing
number of individuals were deemed incurable, fewer patients were released while an increasing
number of patients were admitted. This led to a rapid steady increase in the MSA patient
population from its opening to its eventual closure. Meanwhile, intermittently inadequate
funding, overcrowding, droughts, and high death rates also plagued the MSA. Structural
problems, such as the lack for many years of a boiler for heat and sufficient lighting, as well as
long-term dependence on a pond on the MSA’s grounds for drinking water, also created
intermittently insalubrious living conditions at the MSA. Asylum population size and state
allocated funding shared a cyclical relationship, leading to a growing imbalance between funds
and the number of patients. For instance, during times of economic downturn, unemployment
begat ‘idleness’, which was perceived to be a form of mental illness. More ‘idle’ individuals
were institutionalized, increasing the Asylum’s operating cost, but with a struggling economy,
the state could not fund this growing demand (Barringer 2016).
Patterns of mortality at the MSA shifted over time. Specifically, the pattern of mortality
reflected in cause of death data derived from the admission and discharge records (AD 1855 to
1929) for the MSA suggests consistent increasing death due to chronic and degenerative diseases
during this time period, while infectious disease was less often recorded as a cause of death after
1926 (Zuckerman et al. 2014). Previous analysis of admission and discharge records from the
asylum show dramatic increases in the proportion of mortality from chronic and degenerative
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diseases, such as cardiovascular disease (CVD) and respiratory diseases, as well as nutritional
deficiencies over the course of the early 20th century. These occurred simultaneous with declines
in gastrointestinal and infectious disease mortality (Dafoe et al. 2019; Zuckerman et al. 2014).
This pattern likely reflects improved living conditions in the MSA. It also likely reflects overall
shifts in cause of death for the general national and regional population at the time in correlation
with the second epidemiologic transition (Dafoe et al. 2019; Zuckerman et al. 2014). However,
due to overcrowding, poor living conditions (e.g., inadequate heat, lighting, and clean water),
limited funding, and inadequate diet the second epidemiologic transition was more than 30 years
delayed inside the MSA (Dafoe et al. 2019).
2.10

Comparative Sample: The Robert J. Terry Anatomical Collection:
The Robert J. Terry Anatomical Collection, currently housed at the National Museum of

Natural History (NMNH), is used as a comparative skeletal sample in this study. The use of a
comparative sample provides a benchmark to which the data collected in this study can be
compared against in order to understand what aspects of frailty, resilience, and early-life stress
are specific to the living conditions and patients in the MSA.
The Terry Collection is a documented skeletal collection composed of 1,728 individuals
who died in St. Louis, MO between 1910 and 1967, although the majority of the Collection was
acquired before 1941 (Hunt and Albanese 2005). They range in age from 14 to 102 years at
death, although most died between 20 and 80 years old (Hunt and Albanese 2005). The mean age
at death for males is 53 years and for females is 58 years. Birth years range from 1828 to 1943.
In total, the Terry Collection represents 950 males and 658 females (Hunt and Albanese 2005).
During the Reconstruction period and Jim Crow era, Missouri saw an influx of immigration from
Southern states. Thousands of individuals left states in the Deep South, such as Mississippi and
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Alabama, motivated by the poor economy (Collins 1997; Collins and Wanamaker 2014) and the
structural violence and racial terror of these states (Sernett 1997). Many of the individuals in the
Terry Collection were part of this migration. They deceased in mental asylums, prisons and jails,
in public hospitals, and as indigents. Upon their death, family members did not (or were unable
to) claim their bodies and they became state property, resulting in dissection and eventual
inclusion in the Terry Collection (Hunt and Albanese 2005). Available documentation for each
individual includes a morgue form that lists sex, age, and social race. In some cases, a dental
chart, anthropometric and anthroposcopic data forms, a bone inventory list, a skeletal index card,
and/or a summary checklist of documents are also available (Hunt and Albanese 2005). Largely
as a result of this level of documentation, the Terry Collection has been used extensively in a
variety of osteological studies during the 20th and 21st centuries (Hunt and Albanese 2005).
The reasons for selecting the Terry Collection for comparison are three-fold. First,
extensive research on this sample means that all of the biomarkers in the SFI, including AMTL,
can be compared between the two samples. While comparable frailty indices cannot be
constructed with the available data for the Terry (Coolidge 2016; de la Cova 2008; Gengo 2014;
Hunt and Bullen 2007), crude prevalence can be compared. While other roughly comparable
archaeologically-derived samples could be used here (e.g., Cedar Grove Cemetery, Freedman’s
Cemetery, Albert J Phillips Memorial Cemetery, Monroe County Poorhouse), data on crude
prevalence for the biomarkers included in this study are not as comprehensively available for the
samples.
Second, the Terry Collection is temporally congruent to the MSA, consisting of remains
primarily acquired and incorporated between 1910 and 1941 (Hunt and Albanese 2005).
Importantly, the above archaeologically-derived samples also represent pre-second
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epidemiologic transition populations (Haines 1994), while the MSA sample represents a
transitioning and post-second epidemiological transition population (Dafoe et al. 2019;
Zuckerman et al. 2014), as does the Terry. Comparisons of pre- and post-second epidemiologic
transition samples are not useful in this study given that the goal of comparison is to understand
frailty across two similar samples and to explicate any differences in frailty that are discovered.
Additionally, Wilson (2014) found that the relationship between early-life stress and adulthood
mortality varied across space, time, and cultures. This highlights the need for comparison of
temporally, spatially, and culturally similar skeletal samples when investigating issues of stress,
frailty, and resilience in the past.
Third, the individuals in the Terry Collection and in the MSA sample both represent
marginalized populations. Importantly, it recognized that while individuals in both samples died
in poor living conditions and were of low SES at time of death (Barringer 2016; de la Cova
2008; Hunt and Albanese 2005), their early-life experiences may not have occurred in these
impoverished environments (de la Cova 2008). As noted above, individuals in both the Terry and
the MSA derived from diverse backgrounds prior to migration or institutionalization,
respectively. Additionally, both samples represent individuals who lived in the Antebellum,
Reconstruction, and Jim Crow-era South, which has important implications for the embodiment
of discrimination, poverty, and marginalization (Barringer 2016; de la Cova 2008; Hunt and
Albanese 2005).
Importantly, the Terry Collection tends to over-represent older age categories, males, and
impoverished individuals (Hunt and Albanese 2005). Therefore, this skew is considered in this
study in regards to differences in demographic composition (e.g., age and sex distribution)
between this Collection and the MSA sample. Additionally, sex information for individuals in
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the Terry Collection is derived from medical records rather than through skeletal analyses. This
difference may account for some sex-based differences between the two samples. However,
given that Dr. Robert Terry was interested in all human variation and pathologies, the Collection
likely does not systemically include or exclude individuals based on the presence or absence of
skeletal anomalies, such as pathologies and fractures (de la Cova 2008). Therefore, comparing
the prevalence of the biomarkers between these samples should not be significantly impeded by
the biases of the Terry.
2.11

Ethical Statement
I currently belong to two academic associations, the American Association of Physical

Anthropologists (AAPA) and the Paleopathology Association (PPA), both of which have codes
of ethics that must be upheld by all members. These ethical statements can be found online:
AAPA Code of Ethics https://physanth.org/search/?q=aapa+code+of+ethics; PPA Code of Ethics
https://paleopathology-association.wildapricot.org/.
The MSA sample provides an excellent opportunity to consider and define ethical use of
human remains for the generation of scientific knowledge. This is in large part because many
patients in the MSA did not fully consent to being institutionalized and many were subject to
structural violence, via Jim Crow, prior to institutionalization. Therefore, it is our responsibility
as scientists to acknowledge that we are indebted to these individuals for their contributions to
scientific knowledge and to the careers of the researchers who study these remains. Additionally,
the long-term conservation of remains in the sample must be ensured, both as an ethical
obligation to science and to these individuals. I personally addressed conservation of the MSA
sample by aiding in the construction and organization of a new lab for these remains, ensuring
proper temperature control in the lab, and confirming that the remains were packaged in ways
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that minimized the risk of damage (e.g., tissue paper, epifoam, skull rings). Destructive analyses
were not necessary for achieving results in this study and therefore no destructive methods were
used.
Aside from ethical treatment of the skeletal remains, several other ethical considerations
were made in this study. First, the Asylum Hill Project was provided with a copy of the proposal
for this study and the final version of the thesis for approval. This research consortium seeks “to
preserve, rigorously investigate, and promote the public history and scientific value of the
Mississippi State Insane Asylum and to honor the experience and legacy of the individuals who
were its patients over an important 80-year period in the history of medicine, mental illness,
social institutions, in the State of Mississippi” (Didlake and Gibson 2018). Many descendants of
those institutionalized at the MSA have contacted the Project and members of the Project seek to
work with these descendants as much as possible. However, given that individuals in the MSA
sample are not identified and cannot feasibly be identified via aDNA at this time, the descendant
community was not included in this study. More information on the Asylum Hill Project is
available online (https://www.asylumhillproject.org/). Second, this study will be published
online through the Mitchell Memorial Library at Mississippi State University and will be
published in an academic journal in a timely fashion. Finally, all reasonable requests for access
to this document and to the data generated as part of this study will be considered.
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CHAPTER III
METHODS
3.1

Research Design
This study makes two modifications to the original SFI. First, the trauma category (i.e.

fractures) is excluded. Fractures may result from a wide variety of causes or stressors, such as
osteoporosis, accident, and interpersonal violence. Previous research on the MSA sample has
found evidence of multiple cranial depression fractures located above the hat brim line (Banks
and Osterholtz 2018). Fractures in this location are associated with interpersonal violence
(Guyomarc'h et al. 2010; Kremer et al. 2008), indicating that individuals in the sample likely
experienced this form of trauma. Given this, multiple causes of fractures must be considered to
account for the differential stress, specifically psychosocial stress (e.g., fear of another person),
associated with interpersonal violence as compared to accidental or osteoporotic fracturing. The
SFI considers fractures as evidence for psychosocial stress but does not account for the different
types of psychological stress experienced during interpersonal violence relative to accidents that
produce fractures. The incorporation of fractures as one category, regardless of cause, therefore
can be seen as an oversimplification of trauma and traumatic stress. In fact, fractures are not
included as biomarkers in many frailty indices for modern populations, likely due to this
complication (e.g., Binru et al. 2019; Burn et al. 2018). When fractures are included, specific
types of fractures – such as ‘age-related’ fractures or ‘fragility fractures’ – may be explicitly
included or excluded (Abbasi et al. 2019; Gahbauer et al. 2008). More often, fractures are seen as
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an outcome of increasing frailty, such as increasing age or advancing osteoporosis or
osteoarthritis (e.g., Ensrud et al. 2007; O’Brien and McDougall 2019). A more refined approach
to trauma in the MSA sample is required if fractures are to be included in an SFI applied to it.
However, such an investigation falls outside the scope of this project. As Marklein and Crews
(2017) found that removing biomarkers from the SFI does not weaken the model significantly,
the removal of fractures from the SFI used here does not innately change the model but rather
alters the model within established guidelines.
Second, multiple frailty indices (i.e. Overall SFI, Nutrition SFI, Infection SFI, Activity
SFI) were used in addition to crude prevalence in order to maximize the available sample size.
Additionally, the status (i.e. active, healing, healed) of several biomarkers (i.e. periosteal
reactions, PD, PH/CO, AMTL) was assessed in order to assess resilience. Poor preservation of
the MSA sample decreased the number of individuals for which more than half of the biomarkers
were observable, greatly reducing the final sample size. To accommodate this, four additional
frailty indices were constructed following guidelines and categories provided by Marklein and
Crews (2017). These specific indices are discussed in detail in section 3.6 of this chapter.
Calculating the crude prevalence of each biomarker allowed for a larger sample size to be
considered for each. Doing this calculation does involve some complications. Specifically,
skeletal samples pose the issue that they are not ‘randomly selected’, as is the standard for
modern studies of disease prevalence (Waldron 2009). Rather, skeletal samples are a reflection
of the individuals who died and were buried and whose remains were later preserved and
recovered (Waldron 2009). For this study, the skeletal sample represents a non-random sample
of individuals from the patient population of the MSA. It also represents individuals whose
remains are incomplete. Additionally, the age structure of skeletal samples is not reflective of the
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age structure of the living population (Waldron 2007). However, in this study, analyzing crude
prevalence provides an added layer of information regarding population-level health. Given the
small sample size and poor preservation, this added layer is necessary and useful.
Other biomarkers that are not included in this study or in the SFI, such as vertebral
transverse diameter (Newman and Gowland 2015), could be and have been used to explore the
relationship between early-life and adult health. However, they were not included in the original
set of biomarkers used in the SFI (Marklein et al. 2016) and therefore will not be applied here.
Rather, this study focuses on manipulating the existing SFI for use on small, poorly preserved
skeletal samples rather than testing the validity of adding new biomarkers to the SFI.
Additionally, although the equal weighting of biomarkers is a limitation of the SFI, only
presence and absence, rather than severity, was recorded here, consistent with the original
methods of Marklein and colleagues (2016).
3.2

Hypotheses
The following hypotheses address research question 1 and its associated sub-questions,

which were outlined in the Introduction.
•

Hypothesis 1: Given that high frailty is correlated to increased risk of morbidity
and mortality, skeletally estimated age will significantly correlate with each SFI
(i.e., Overall, Nutritional, Infection, Activity).

•

Hypothesis 1a: If a relationship exists between each SFI (i.e. Overall, Nutritional,
Infection, Activity) and age, the highest SFI scores will correlate with the
youngest age category (<30) indicating that the frailest individuals die young.

•

Hypothesis 1b: If a relationship exists between each SFI (i.e. Overall, Nutritional,
Infection, Activity) and age, no single SFI biomarker will contribute more
significantly to this relationship than any other biomarker. The various SFIs will
explain more variance in the SFI-age relationship than any single biomarker of
skeletal frailty.
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•

Hypothesis 1c: The relationship between age and each SFI (i.e. Overall,
Nutritional, Infection, Activity) will differ between the sexes. Frail males will be
more likely to die young than their female counterparts. Therefore, female frailty
will increase with age given that females are more resilient to stressors and thus
accumulate markers of frailty over the life course as they survive through these
stressors.

•

Hypothesis 1d: The frequency of early-life stress indicators (i.e. LEH) will be
consistent through the age-at-death categories, indicating that no relationship
exists between early-life stress and increased risk of morbidity and mortality.

The following hypotheses address research question 2 and its associated sub-questions,
which were outlined in the Introduction.
•

Hypothesis 2: Given known differences in frailty, morbidity, and mortality based
on sex a significant correlation will exist between sex and each SFI score (i.e.
Overall, Nutritional, Infection, Activity).

•

Hypothesis 2a: Females will have consistently higher SFI scores (i.e. Overall,
Nutritional, Infection, Activity) given that females are more resistant to stressors
and therefore live long enough to accumulate more stressors.

•

Hypothesis 2b: No single biomarker or set of biomarkers will explain more
variance between the sexes than any other biomarker or set of biomarkers
indicating that the SFIs (i.e. Overall, Nutritional, Infection, Activity) a better
measure of frailty than any one non-specific indicator.

•

Hypothesis 2c: The presence of LEH will be equivalent between the sexes.

The following hypotheses address research question 3 and its associated sub-questions,
which were outlined in the Introduction.
•

Hypothesis 3: A significant correlation will exist between the presence of an
early-life stress indicator (LEH) and higher SFI scores (i.e. Overall, Nutritional,
Infection, Activity).

•

Hypothesis 3a: If a significant relationship exists, no single adulthood biomarker
or set of biomarkers will correlate more closely with the presence of an early-life
stress biomarker, indicating that the SFIs (i.e. Overall, Nutritional, Infection,
Activity) are more closely related to early-life stress than any single measure of
adult frailty.

•

Hypothesis 3b: If a significant relationship exists, LEH will not have a higher
correlation with high SFIs (i.e. Overall, Nutritional, Infection, Activity).
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The following hypotheses address research question 4.
•

Hypothesis 4a: Younger individuals will have a higher prevalence of healing or
healed biomarkers, indicating higher resilience in younger individuals.

•

Hypothesis 4b: Males will have lower resilience (e.g., a higher prevalence of
active lesions) as they are physiologically less able to cope with stressors.

•

Hypothesis 4c: Individuals with markers of early-life stress will have lower
resilience (e.g., a higher prevalence of active lesions) as they are less able to cope
with stressors.

The following hypotheses address research question 5.
•

3.3

Hypothesis 5: As a null hypothesis, there will be no differences in frailty,
resilience, or early-life stress between the MSA sample and the Terry Collection.

Sex, Age, Gender & Ancestry
Sex was estimated using both cranial and pelvic morphology based on established

standards (Buikstra and Ubelaker 1994). While the use of multiple skeletal landmarks increases
accuracy (Meindl et al. 1985), sex estimation based on pelvic morphology is proven to be more
accurate than that based on cranial morphology. Accordingly, when sex estimation based on the
cranium conflicted with findings from the pelvis, pelvic scores were weighed more heavily.
Individuals scored as ‘male’ and ‘probable male’ were condensed into the ‘male’ category used
for statistical testing. Individuals scored as ‘female’ and ‘probable female’ were also condensed
into the ‘female’ category for statistical testing. Individuals scored as ambiguous or
indeterminate were excluded from the sex-specific analyses (i.e. statistical testing associated
with research question 2). These individuals were included in statistical analyses that were not
specific to sex (i.e. statistical testing associated with research questions 1, 3, 4, and 5). The
assumption is made here that sex plays a fundamental role in frailty and resilience.
While there are many ways to estimate gender in bioarchaeology (Sofaer 2012), a method
42

was followed here that estimates gender from skeletal sex. Mississippi, like most of the Deep
South employed a binary, two-gender system during the late 19th and early 20th century,
primarily recognizing masculine and feminine gender identities (Bercaw et al. 2009).
Furthermore, many social and biological experiences over the life course, such as overall health
(Smith 2009), reproduction (McMillen 2009), and occupation (Sharpless 2009), were strongly
influenced by these binary gender roles. Accordingly, an assumption is made that any genderbased differences in frailty would follow a bimodal distribution, reflecting these gender
differences in contemporary Mississippi culture. Sex-based patterns in frailty in the MSA sample
are interpreted relative to what they may tell us about sex-based physiological differences in
frailty and resilience. They are also used to explore gender-related patterns of frailty and
resilience.
Age was estimated via transition analysis (Boldsen et al. 2002) using the forensic prior in
the ADBOU software (available at http://math.mercyhurst.edu/~sousley/Software/). While
transition analysis may lead to underestimation of the oldest age categories (Boldsen et al. 2002),
such underestimation would be consistent across the sample. Therefore, the categories remain
indicative of population-wide trends rather than indicative of specific numeric values (DeWitte
2017). The age categories employed here are <30 years, 30-50 years, and 51+ years. These age
categories differ slightly from standard age categories in osteology (e.g., <35, 35-50, >50).
However, given the high numbers of young individuals in the MSA sample, the youngest age
category was narrowed to provide (a) more statistical power to the older (i.e. 30-50, >50) age
categories and (b) to better understand frailty in the youngest age cohort (i.e. <30).
Ancestry was not estimated due to its proven inaccuracy (Goodman 1997; Goodman 2000;
Hubbe and Neves 2007; Sierp and Henneberg 2015). However, it is important to note that wards
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within the MSA were segregated, and the ‘Negro’/’Colored’ wards often experienced more
significant overcrowding, poorer nutrition, and lower standards of living (Zuckerman et al.
2014). The MSA skeletal sample is likely heavily skewed towards this demographic due to
higher mortality in the ‘Negro’ wards, especially during the early 20th century (Plemons 2016).
3.4

Statistical measures for ‘observable’ status of indicators
When assessing the presence of any given biomarker, it is also necessary to determine

whether it is appropriate to assess each biomarker on a given individual. This is largely due to
issues of skeletal preservation and completeness. For example, if no dentition is preserved, it is
not appropriate or even possible to assess LEH. Additionally, if only a handful of elements are
present from an individual, a lack of lesions or abnormalities on these few elements does not
mean that lesions were also absent on elements that are not present (e.g., due to taphonomic
damage). To accommodate issues of incomplete preservation, such as with archaeologicallyderived skeletal material, some researchers choose to only assess certain biomarkers on certain
elements or at certain landmarks. For example, some studies only assess LEH on specific teeth
(e.g., mandibular canines) (e.g., Cucina 2011; DeWitte 2010; Yaussy et al. 2016) or only assess
periosteal reactions on the anterior tibiae (e.g., DeWitte 2014). While these are valid,
conservative approaches, restricting data collection to a single element for biomarkers in the SFI
that may occur on any element (e.g., periosteal reactions, neoplasms), may underestimate frailty.
Further, the use of these approaches on samples with poor preservation and significant
taphonomic damage, as is the case with the MSA sample, substantially reduces the amount of
data that could be collected.
This section outlines the minimum standards used in this study for a biomarker to be
considered ‘observable’. In some cases, this is outlined in the scoring systems and diagnostic
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criteria associated with the biomarkers. For instance, PD is considered to be ‘observable’ only
when two adjacent teeth are in occlusion (Kerr 1988). In other cases, the standard for
‘observable’ is determined using statistical methods after the remains have been analyzed, as is
described below.
3.4.1

Methods and Results for Statistical Determination of ‘observable’ Criteria
Several biomarkers in the SFI were statistically analyzed in R using Fisher’s Exact tests

and partitioned Fisher’s Exact tests in order to determine if there was a statistically significant
relationship between the state of preservation and the likelihood of a particular biomarker being
scored as present. The biomarkers tested in this fashion are LEH, periosteal reactions, PH, OA,
IVD, and RCD. Two biomarkers, neoplasms and osteoporosis, were not observable in the MSA
sample and therefore statistical tests could not be run. Two additional biomarkers, PD and
rickets, were also not statistically tested because a separate preservation standard, which was not
statistically determined, was used.
First, the association between the presence of LEH and the number of teeth present for
observation for each individual (Table 3.1) was tested via a Fisher’s Exact test with an α level of
.05. This test did not produce a statistically significant value (p=0.9274) so it is concluded that
there is no association between the number of teeth present for each individual and the likelihood
of LEH being detected. For that reason, LEH should be considered to be ‘observable’ for
individuals with any dentition present. It should be noted that a tooth was only scored as present
when at least half of the crown was present.
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Table 3.1

LEH vs. Observable Dentition

1-7
8-15
16-23
24-32
teeth
teeth
teeth
teeth
LEH Absent 6
8
8
17
LEH
3
2
4
8
Present
Contingency table used to test the association between LEH and the number of teeth present for
observation.
Second, the association between average skeletal preservation and the likelihood of
detecting periosteal reactions was tested using a Fisher’s Exact test (Table 3.2). Skeletal
preservation was determined by scoring each element on a scale from 0 to 4 (i.e. 0=element
missing; 1=element <25% present; 2= element 25-49% present; 3=element 50-74% present; and
4=element >75% present) and then averaging these scores for each individual to provide an
average skeletal preservation score. Only portions of each element with intact cortical bone were
considered present. A Bonferroni correction (Bonferroni 1935) was used to correct for familywise error. Since four tests (Table 3.2, Table 3.3, Table 3.4, Table 3.5) were run, the α level of
.05 was divided by 4 (.05/4=.0125). Therefore, the p-value must fall below .0125 to be
considered significant. The Fisher’s Exact test comparing skeletal preservation to periosteal
reaction identification produced a statistically significant value (p=2.71e-07), indicating a
significant relationship between level of preservation and the likelihood of detecting a periosteal
reaction. In order to understand where this significance occurs (e.g., between burials with less
than 25% preservation and burials with more than 25% preservation), orthogonally partitioned
Fisher’s Exact tests were run (Table 3.3, Table 3.4, Table 3.5). A summary of these results is
presented in Table 3.6. Based on this set of partitioned tests, it is statistically more likely for
periosteal reactions to be detected on burials with greater than 50% preservation. Therefore,
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periosteal reactions will only be considered to be ‘observable’ for individuals with an overall
inventory score of 3 or 4, indicating greater than 50% preservation.
Table 3.2

Periosteal reactions vs. Skeletal Preservation
1-24%
present
26

25-49%
present
7

50-74%
present
0

75-100%
present
1

Periosteal
reactions Absent
Periosteal
6
13
13
1
reactions
Present
Contingency table used to assess the relationship between overall skeletal preservation and the
likelihood of scoring periosteal reactions.

Table 3.3

Partitioned Contingency Table – Periosteal reactions vs. <25% and 25-49%
preservation
1-24% present
26

25-49% present
7

Periosteal
reactions Absent
Periosteal
6
13
reactions
Present
The first orthogonally partitioned contingency table used to identify the locations of significant
relationships within Table 2. Here, the likelihood of scoring periosteal reactions between burials
with less than 25% preservation and between 25% and 49% preservation is compared using a
Fisher’s Exact test.
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Table 3.4

Partitioned Contingency Table – Periosteal reactions vs. <50% and 50-74%%
preservation
1-49% present
33

50-74% present
0

Periosteal
reactions Absent
Periosteal
19
13
reactions
Present
The second orthogonally partitioned contingency table used to identify the locations of
significant relationships within Table 2. Here, the likelihood of scoring periosteal reactions
between burials with less than 50 % preservation and between 50 and 74% preservation is
compared using a Fisher’s Exact test.

Table 3.5

Partitioned Contingency Table – Periosteal reactions vs. <75% and >75%
preservation
1-74% present
33

75-100% present
1

Periosteal
reactions Absent
Periosteal
32
1
reactions
Present
The third orthogonally partitioned contingency table used to identify the locations of significant
relationships within Table 2. Here, the likelihood of scoring periosteal reactions between burials
with less than 75% preservation and more than 75% preservation is compared using a Fisher’s
Exact test.
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Table 3.6

Summary table of results for the above partitioned Fisher’s Exact tests.

Preservation Levels
Contingency Table
Tested
<25% preservation vs.
Table 3.3
25-49% preservation
<50% preservation vs.
Table 3.4
50-74% preservation
<75% preservation vs.
Table 3.5
>75% preservation
Significant p-values indicated with an asterisk.

Degrees of Freedom

p-value

1

.001158*

1

2.115e-05*

1

1

Third, the relationship between cranial vault (e.g., frontal, parietals, and occipital)
preservation and the likelihood of detecting PH was assessed via a Fisher’s Exact test with an α
level of .05 (Table 3.7). This test did not produce a statistically significant value (p=.4124),
indicating that the state of preservation did not significantly influence the likelihood of detecting
PH. Therefore, PH was considered to be ‘observable’ when any cranial vault fragments with
intact ectocranial cortex were present.
Table 3.7

PH vs. Cranial Vault Preservation

1-24% present 25-49% present 50-74% present 75-100% present
PH Absent 2
13
10
6
PH Present 0
5
2
5
Contingency table used to assess the relationship between cranial vault preservation and the
likelihood of scoring PH.
Fourth, the relationship between average joint preservation and the likelihood of
detecting OA was tested using a Fisher’s Exact test (Table 3.8). Joint preservation was
determined by scoring each joint, except for joints of the wrists, ankles, hands, and feet, on a
scale from 0 to 4 (i.e. 0=element missing; 1=element <25% present; 2= element 25-49% present;
3=element 50-74% present; and 4=element >75% present) and then averaging these scores for
each individual to provide an average joint preservation score. No individuals had an average
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score of 4, so only scores 1 to 3 are analyzed here. A Bonferroni correction (Bonferroni 1935;
1936) was used to correct for family-wise error. Since four tests (Table 3.8, Table 3.9, Table
3.10, Table 3.11) were run, the standard alpha-value of .05 was divided by 4 (.05/4=.0125).
Therefore, the p-value must fall below .0125 to be considered significant. This test produced a
statistically significant value (p=.004429) indicating that the likelihood of detecting OA is
dependent on joint preservation. In order to understand where this significance occurs (e.g.,
between burials with less than 25% joint preservation and burials with more than 25% joint
preservation), non-orthogonally partitioned Fisher’s Exact tests were run (Table 3.9, Table 3.10,
Table 3.11). A summary of these results is presented in Table 3.12. Based on this set of
partitioned tests, it is statistically more likely for OA to be detected on burials with greater than
25% joint preservation. Therefore, OA will only be considered to be ‘observable’ for individuals
with an average joint inventory score of 2 or 3 indicating greater than 25% preservation.
Table 3.8

OA vs. Joint Preservation

1-24% present 25-49% present 50-74% present
OA Absent
25
2
0
OA Present
11
7
2
Contingency table used to assess the relationship between joint surface and margin preservation
and the likelihood of scoring OA. No individuals had greater than 75% preservation of joint
surfaces.

Table 3.9

Partitioned Contingency Table – OA vs. <25% and 25-49% preservation

1-24% present 25-49% present
OA Absent
25
2
OA Present
11
7
The first orthogonally partitioned contingency table used to identify the locations of significant
relationships within Table 3.8. Here, the likelihood of scoring OA between burials with less than
25% joint surface preservation and more than 25% joint surface preservation is compared using a
Fisher’s Exact test.
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Table 3.10

Partitioned Contingency Table – OA vs. <50% and 50-75% preservation

1-49% present 50-74% present
OA Absent
27
0
OA Present
18
2
The second orthogonally partitioned contingency table used to identify the locations of
significant relationships within Table 3.8. Here, the likelihood of scoring OA between burials
with less than 50% joint surface preservation and between 50 and 74% joint preservation is
compared using a Fisher’s Exact test.

Table 3.11

Partitioned Contingency Table – OA vs. <25% and >25% preservation

1-24% present 25-74% present
OA Absent
25
2
OA Present
11
7
The third orthogonally partitioned contingency table used to identify the locations of significant
relationships within Table 3.8. Here, the likelihood of scoring OA between burials with less than
24% joint surface preservation and greater than 25% joint preservation is compared using a
Fisher’s Exact test.

Table 3.12

Summary Results for OA partitioned Fisher’s Exact tests.

Preservation Levels
Contingency
Tested
Table
<25% preservation vs. Table 3.9
25-49% preservation
<50% preservation vs. Table 3.10
50-74% preservation
<25% preservation vs. Table 3.11
>25% preservation
Significant p-values indicated with an asterisk.

Degrees of Freedom

p-value

1

.01928

1

.1758

1

.004429*

Fifth, the relationship between vertebrae preservation and the likelihood of detecting IVD
was tested using a Fisher’s Exact test with an α level of .05 (Table 3.13). Fisher’s exact tests
showed no statistically significant relationship (p=.1448) between the number of vertebral centra
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present and the likelihood of being diagnosed with IVD. Therefore, IVD was considered to be
‘observable’ when any centra were present.
Table 3.13

IVD vs. Vertebrae Preservation

IVD Absent
IVD Present

1-24%
present
6
2

25-49%
present
7
1

50-74%
present
5
1

75-100%
present
1
1

Contingency table used to assess the relationship between vertebrae preservation and the
likelihood of diagnosing IVD.
Finally, the relationship between preservation of skeletal elements involved in the rotator
cuff and the likelihood of detecting RCD was tested using Fisher’s Exact tests with an α level of
.05. RCD can be observed at four locations on each side of the body: the acromion and coronoid
process on the scapula, the acromial end of the clavicle, and the bicipital groove on the humerus.
Both the number of sides present (e.g., 1 or 2) and the number of landmarks (total=8, 4 per side)
were tested for relationships with RCD diagnosis. Fisher’s Exact tests showed no statistically
significant relationship (p=0.775) between the number of locations (i.e. acromion, coronoid
process, acromial end, and bicipital groove) observable and the likelihood of RCD being
diagnosed (Table 3.14). Additionally, Fisher’s exact tests showed no statistically significant
relationship (p=.2143) between the number of sides observed (i.e. right, left, or both) and the
likelihood of RCD being diagnosed (Table 3.15). Therefore, all individuals with at least one
observable location on one side were considered to be ‘observable’ for RCD.
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Table 3.14

RCD vs. Preserved Surfaces

1 Surface 2 Surfaces
3 Surfaces 5 Surfaces 6 Surfaces
RCD Absent 6
4
1
1
1
RCD Present 1
2
0
0
0
Contingency table used to assess the relationship between the number of preserved surfaces and
the likelihood of diagnosing RCD. No individuals had 4 preserved surfaces and no individuals
had greater than 6 preserved surfaces.

Table 3.15

RCD vs. Preserved Sides

1 Side 2 Sides
RCD Absent 10
1
RCD Present 3
2
Contingency table used to assess the relationship between the number of preserved sides and the
likelihood of diagnosing RCD.
3.4.2

Criteria for ‘observable’ scoring
The following section summarizes the criteria used in this study for considering each

biomarker to be ‘observable’. The criteria based on statistical testing should not be applied to
other skeletal samples; they are unique to the MSA sample used here. Rather, novel statistical
assessments should be run using the data generated from a given sample. However, other criteria,
such as the criteria for considering PD, rickets, and femoral metrics to be observable, are
transferable to other samples because they are not statistically determined.
•

LEH – LEH is considered to be ‘observable’ for all individuals with any dentition
present.

•

Periodontal Disease – Periodontal disease (PD) was assessed using Kerr’s (1988)
scoring system, which requires that adjacent teeth be in occlusion with no
surrounding taphonomic damage in order for PD to be scored (1-5; 0 = teeth on
either side lost antemortem or the alveolar bone/ septum damaged postmortem).

•

Periosteal reactions – Based on the above statistical tests, periosteal reactions are
considered to be ‘unobservable’ when an individual was less than 50% complete.
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3.5

•

PH – PH is considered to be ‘observable’ for individuals with any cranial vault
bone (e.g., frontal, parietals, and occipitals) with intact cortex.

•

Rickets/Osteomalacia – Because no cases of rickets or osteomalacia were
diagnosed in this sample, it was not possible to test statistical associations.
Individuals with at least one arm (i.e. humerus, radius, or ulna) and leg bone (i.e.
femur, tibia, or fibula) scored as at least 25% present were considered to be
‘observable’ for bowing associated with rickets.

•

Neoplasms – No cases of neoplasms were diagnosed in this sample. Since, like
periosteal reactions, neoplasms can occur on any bone in the body, the statistical
standard created for periosteal reactions is also be applied to neoplasms.
Neoplasms are considered to be ‘observable’ when an individual is more than
50% complete.

•

Osteoporosis – No cases of osteoporosis were identified in this sample, so a
statistical determination of skeletal completeness required for identifying
osteoporosis cannot be conducted. Since osteoporosis can occur in any skeletal
element, all individuals are considered to be ‘observable’ for osteoporosis.

•

Osteoarthritis – OA is considered to be ‘observable’ when the joint surface
presence is greater than 25%.

•

Intervertebral Disc Disease – IVD is considered to be ‘observable’ when any
centra are present.

•

Rotator Cuff Disorder – All individuals with at least one observable location on
one side are considered to be ‘observable’ for RCD.

•

Femoral Metrics – For the maximum femoral length to be measured, the femur
must be complete with intact condyles and femoral head. This standard was not
met for any individuals in this sample. In order to measure the maximum femoral
head diameter, the cortex surrounding the entire margin of the femoral head must
be intact. This was the case for only two individuals in this sample. Due to lack of
preservation and previous cross sectioning of many femora, femoral metrics were
largely unobservable and are not used in this study.

Skeletal Frailty Index – Methods used in analysis
The previous section outlined the criteria for considering each biomarker to be

‘observable’ for each burial. Once a biomarker is considered to be ‘observable’, the presence or
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absence of that biomarker can then be assessed. The criteria used in this study for assessing the
presence or absence of each biomarker are outlined below.
•

Femoral Maximum Length - Femoral length was recorded from the head to the
condyles, placing both medial condyles flush with the end of the osteometric
board (Moore-Jansen et al. 1994). For this study, no femora were complete
enough for this measurement. Therefore, this biomarker is not used in this study.

•

Femoral Head Diameter - The maximum diameter of the femoral head was
recorded using digital calipers (Moore-Jansen et al. 1994). Only two femoral
heads were intact enough for this measurement. Therefore, this biomarker is not
used in this study.

•

LEH - The buccal surface of all present teeth was analyzed macroscopically under
good lighting. A score of ‘1’ was assigned when the hypoplasia was both palpable
with a fingernail and visible. While macroscopic analysis may lead to an
underestimation of LEH presence (Hassett 2014), underestimation ensures that the
conclusions regarding this biomarker are conservative.

•

PD – PD was scored as present when bone loss in the interspace between teeth in
occlusion led to an abnormal depressed or concave appearance, following
methods outlined by Kerr (1988).

•

Periosteal reactions - Periosteal reactions were scored as present when an osseous
plaque (healed or active) is present and is greater than 2 cm in length (Ortner
2003).

•

PH & CO - Both healed and active lesions were scored as ‘present’ when multiple
pores were visible macroscopically on either the superior eye orbits (CO) or on
the parietal bones (PH). Very few orbits were well preserved in this sample.
Therefore, CO is not included as a biomarker in this study, though PH is.

•

Rickets/Osteomalacia - Rickets and osteomalacia manifest in similar forms and
thus the two are not differentiated when scored. The presence of rickets and
osteomalacia was assessed using only long bones. Other criteria for identifying
these conditions, which include assessing flattening of the ribs at the
costochondral junction, vertebral collapse with ‘scalloping’ of the endplate, pelvic
deformation ‘flattening’ or ‘folding’), and anterior of the sacrum (Ortner and
Putschar 1981), could not be applied to the MSA sample due to poor preservation
of these elements. Since only adult individuals are present in the MSA sample,
cranial deformation associated with vitamin D deficiencies was not considered.
While periosteal reactions and stunting are associated with rickets, they are scored
elsewhere in the SFI and therefore were not considered indicative of
rickets/osteomalacia in the present study.
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•

Neoplasms - Neoplasms were analyzed macroscopically according to guidelines
presented by Ragsdale and colleagues (2017) via differential diagnosis.
Neoplasms were not scored as present when only ‘positive’ (e.g., productive)
periosteal reactions are present. Instead, these lesions were instead scored as
periosteal reactions as outlined above. ‘Negative’ (e.g., erosive) periosteal
reactions were scored as neoplasms. Radiographic analysis can be used to identify
neoplasms but was not employed here.

•

Osteoporosis - Osteoporosis was scored as ‘present’ when bones were determined
to be abnormally light in weight or when reticulated perforations were present
(despite no inflammatory response), following Ortner and Putschar (1981). Cross
sections of bone were not cut for diagnosis but existing cross sections cut for a
previous study (Davenport 2016) were analyzed when available. Also, if the
trabeculae were exposed via taphonomic processes, the trabeculae were assessed
for osteoporotic bone according to Ortner and Putschar (1981). Poor preservation,
leading to lack of protein within the skeletal material, and taphonomic damage to
the metaphyses and epiphyses largely prevented the assessment of weight and
reticulated perforations. Therefore, osteoporosis is not included in this study.

•

OA - OA was scored as ‘present’ when joint surfaces exhibited eburnation or
porosity or when joint margins were characterized by osteophytes/osteophytic
lipping, syndesmophytes, or porosity (Ortner and Putschar 1981) (Ortner and
Putschar 1981; Weiss 2015). Periosteal reactions near joint surfaces were scored
not scored as OA since OA is rarely associated with inflammatory responses
(Ortner and Putschar 1981).

•

IVD - IVD was scored as present when vertebrae were fused, when osteophytic
growths extend more than 5 mm beyond the joint margins, or when macroporosity
on the joint surface is present (Marklein et al. 2016; Waldron 2009).

•

RCD - RCD was scored as ‘present’ according to the criteria outlined by Waldron
(2009). This includes abnormal bony changes to the coronoid and acromial
processes on the scapula, the acromial end of the clavicle, and the bicipital groove
on the humerus.

Use of the SFI requires that each of the biomarkers are observed independently. There are
several biomarkers that are observed at the same locations on the skeleton and therefore require
additional caution to avoid diagnostic overlap. The following criteria were used to ensure
independent analysis of each biomarker. First, both OA and RCD can occur at the shoulder.
However, OA occurs in the glenohumeral joint while RCD does not. Therefore, both OA and
RCD can be independently assessed. Second, given that IVD, OA, and rickets may all be
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observed on the vertebrae, it is necessary to draw a line between each of these diagnoses. To
address potential diagnostic overlap with IVD, rickets was not assessed based on vertebral
collapse. Additionally, OA was only assessed on the superior and inferior articular facets of
vertebrae while IVD was assessed only on the centra of vertebrae. Therefore, there is no overlap
in diagnostic criteria for these three conditions.
3.6

Resilience – Methods used in Skeletal Analyses
The following biomarkers were scored as ‘present’ for resilience when evidence of

healing, whether complete (e.g., no remaining active regions) or ongoing (e.g., some regions of
activity as well as healing), is present: periosteal reactions, PD, PH, and AMTL. The prevalence
of these indicators is compared statistically to age, sex, early-life stress, and each of the SFIs.
3.7

Statistical Methods
Due to sample preservation, a complete 13-biomarker SFI could not be used. Instead, an

8-biomarker SFI could be applied to the MSA. The 8-biomarker SFI (i.e., the Overall SFI)
includes periosteal reactions, PD, neoplasms, rickets/osteomalacia, PH, OA, RCD, and IVD.
Reducing the biomarkers used from the original 13-biomarker SFI does not, however, reduce the
analytical power of the SFI. Marklein and Crews (2017) found that reducing biomarkers from an
SFI does not weaken the model significantly as long as more than six biomarkers are retained.
Therefore, the biomarkers included in the calculated index scores here were reduced according to
methods outlined and supported by Marklein and Crews (2017), rather than those for the original
13-biomarker SFI as proposed by Marklein and colleagues (2016). However, the eight
biomarkers in the Overall SFI could only be recorded on a very small sub-sample (n=8) of
skeletons from the MSA sample (n=67).
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Accordingly, three additional indices were applied to the MSA in order to provide an
additional avenue through which frailty could be explored and to increase the sample size for
which frailty and resilience could be estimated. These additional indices were created following
the categories and standards outlined by Marklein and colleagues (Marklein and Crews 2017;
Marklein et al. 2016). Although these indices include fewer than 6 biomarkers, they are valid
because they measure a specific type of frailty (e.g., nutritional), rather than overall frailty (see
Marklein and Crews 2017). The three smaller indices (e.g., sub-type SFIs) are the Activity Index,
the Infection Index, and the Nutrition Index. The Activity Index is the sum of the activity related
biomarkers: OA, RCD, and IVD. A sub-sample (n=11) of individuals in the MSA could be
considered to be ‘observable’ for all of the biomarkers in this index and were scored. The
Infection Index is the sum of infection-related biomarkers: periosteal reactions, PD, and
neoplasms. A sub-sample (n=11) of individuals in the MSA could be considered to be
‘observable’ for all of the biomarkers in this index and were scored. Finally, the Nutrition Index
is the sum of the nutritional-deficiency related biomarkers: rickets/osteomalacia and PH. A subsample (n=36) of individuals in the MSA could be considered to be ‘observable’ for all of the
biomarkers in this index and were scored. The Overall SFI and the sub-type SFIs were each
tested via Fisher’s Exact tests for statistically significant associations with age and sex, early-life
stress, and resilience. Additionally, crude prevalence for each biomarker was tested for
associations with age, sex, early-life stress, and resilience using Fisher’s Exact tests.
In order to address research questions 1 and 1.a. regarding associations between frailty
and age, the calculated Overall SFI and sub-type SFIs were each tested for statistically
significant associations with age using Fisher’s Exact tests and partitioned Fisher’s exact tests.
To address research question 1.b. the prevalence of each biomarker was assessed for statistically
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significant associations with age using Fisher’s Exact tests. To address research question 1.c., the
contingency tables used to address question 1 and 1.a. were divided by sex, when sample size
allowed, and tested for sex-dependent associations between frailty and age. Further, the
contingency tables used to address research questions 1.b. were divided by sex, when sample
size allowed, and tested for sex-dependent associations between each biomarker and age.
To address research questions 2 and 2.a. regarding associations between frailty and sex,
the calculated Overall SFI and sub-type SFIs were each tested for statistically significant
associations with sex using Fisher’s Exact tests. To address research question 2.b. and 2.c. the
prevalence of each biomarker was assessed for statistically significant associations with sex
using Fisher’s Exact tests. Additionally, to understand sex-dependent mortality patterns, Fisher’s
exact tests were run comparing sex and age estimates.
To address research question 3 regarding associations between frailty and early-life
stress, the calculated Overall SFI and sub-type SFIs were tested for statistically significant
associations with LEH using Fisher’s Exact tests. To address research question 3.a., the
prevalence of each biomarker were assessed for statistically significant associations with LEH
using Fisher’s Exact tests.
To address research question 4, each resilience indicator was assessed for statistically
significant associations relative to age, sex, LEH presence, and calculated Overall SFI and subtype SFI scores. Due to poor skeletal preservation, a cumulative resilience index, similar to the
method used in the SFI, could not be created. Therefore, the prevalence of each resilience
indicator was assessed individually for associations with age, sex, early-life stress, and frailty.
Research question 5 was assessed statistically by comparing the prevalence of each
biomarker in the MSA and in the Terry Collection. Prevalence data for the Terry Collection was
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derived from theses, dissertations, and published literature (Coolidge 2016; de la Cova 2008;
Gengo 2014; Hunt and Bullen 2007). In some cases, the methods used in these studies differ
from those used here. These discrepancies are described in the following sections. Accordingly,
when possible, appropriate adjustments have been made. These adjustments are specified in the
following sections as well. The SFI has not yet been applied to the Terry Collection, so the
different indices employed in this study (i.e. Overall, Nutritional, Activity, Infection), could not
be constructed for the Terry Collection. While a database of pathologies in the Terry Collection
does exist, these data were produced by many different researchers, with different research
objectives, and their methods are not explicitly outlined. Therefore, this database is not used
here.
3.7.1

Terry Collection - LEH
The prevalence of LEH in the MSA sample was compared to the prevalence of LEH in

the Terry Collection via a z score test for two population proportions with data derived from
theses and dissertations by Gengo (2014), de la Cova (2008), and Coolidge (2016). In the case of
de la Cova, only the prevalence of LEH in males was compared. A previous comparison of LEH
in the MSA to similar samples was conducted by Plemons (2016) who found that LEH
prevalence was significantly higher in many comparable samples (e.g., Freedman Cemetery,
Cedar Grove Cemetery, and Monroe County Poorhouse).
3.7.2

Terry Collection - PD
The prevalence of PD in the MSA sample was compared to the prevalence of PD in the

Terry Collection via a z score test for two population proportions with data derived from
Gengo’s (2014) thesis (Tables 4.77 & 4.78). Given that Gengo (2014) used only individuals aged
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25 to 55 years from the Terry, the prevalence of PD in 25 to 55 year old individuals in the MSA
was calculated for comparison. However, using this age range also drastically reduced the
number of individuals (n=4) in the MSA sample who could be used in this comparison.
Therefore, to ensure that this lack of statistical significance was not purely the result of a small
sub-sample size in the MSA, the prevalence of PD in the MSA sample in individuals of all ages
(sub-sample n=14) was also compared to the prevalence derived from Gengo (2014).
3.7.3

Terry Collection - Periosteal reactions
To compare periosteal reactions between the two samples, data derived from Gengo

(2014) and Coolidge (2016) were compared to the data collected for this study. Since Gengo
(2014) only observed periosteal reactions on skeletal elements in the lower-limb (i.e. femora,
tibiae, fibulae), the prevalence of periosteal reactions in the same lower-limb elements in
individuals in the MSA was calculated for comparison. Periosteal reactions on the lower-limb
elements in the MSA sample were considered to be observable when the femora, tibiae, and
fibulae were at least 50% present on both sides. Periosteal reactions were considered to be
present if any periosteal reaction greater than 2 cm was observed on any of these elements.
Coolidge (2016) only scored periosteal reactions on the tibiae and required that the lesions be
bilateral to be scored as present. Therefore, the prevalence of bilateral tibial periosteal reactions
was also calculated for the MSA for comparison. Periosteal reactions in this case were
considered observable if both tibiae were at least 50% present.
3.7.4

Terry Collection - RCD
A published study of rotator cuff disease in the Terry Collection does not exist to date.

However, Hunt and Bullen (2007) published a study of the prevalence of os acromiale, which is
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a lack of fusion of the acromial process, in the Terry Collection. Since clinical literature
identifies in modern populations 42% of individuals with os acromiale will develop RCD
(Abboud et al. 2006) and given that 6.2% of modern RCD cases are associated with os acromiale
(Boehm et al. 2005), the prevalence of RCD in the Terry Collection can be roughly estimated.
Based on this calculation, an estimated 56.65% of individuals in the Terry Collection have RCD.
It should be noted however, that this estimate is calculated using clinical data from modern
populations, which likely differ from populations 100 years ago. While this is recognized to be
an imperfect comparison, given the available data, it is the best option.
Terry Collection - IVD
Like RCD, the prevalence of IVD in the Terry Collection has not been reported in the
published literature. However, one publication, Wilczak and Mulhern (2012), has reported the
prevalence of DISH within the Collection. They report that 69 out of 337 individuals (20.47%)
have DISH. Data from the clinical literature suggests that 55.1% of patients in modern
populations with DISH have IVD, while 50% of individuals without DISH have IVD (Di
Girolamo et al. 2001). Therefore, of the 69 individuals with DISH in the Terry Collection,
approximately 38 individuals with DISH likely have IVD. Additionally, given that 50% of
patients without DISH have IVD, an additional 134 individuals in the sample analyzed by
Wilczak and Mulhern (2012) likely have IVD. In total, 203 out of 337 individuals (60.24%) in
the Terry Collection likely have IVD. This estimate is calculated using clinical data derived from
modern populations, which likely differs from populations 100 years ago, and therefore likely
does not represent the true prevalence of IVD in the Terry Collection. However, this is the best
use of the available data.
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3.7.5

Terry Collection - OA
De la Cova (2008) provides prevalence of OA by joint, rather than an overall prevalence,

and in males only. Therefore, the maximum prevalence of OA in a specific joint in individuals
from the MSA sample is used as a comparison here. de la Cova reports that the highest
prevalence of OA can be found in the shoulder joint, occurring in 96.52% of individuals.
Therefore, this value represents the minimum number of individuals with OA at any joint in the
Terry Collection. The prevalence of OA in skeletons estimated to be male in the MSA sample
was compared to the maximum prevalence (i.e., 96.52% in the shoulder joint) reported by de la
Cova (2008). Additionally, the prevalence of OA in the MSA not restricted by sex was compared
to the data derived from de la Cova (2008).
3.7.6

Terry Collection - Rickets
The prevalence of rickets and osteomalacia in the MSA sample was compared to the

prevalence of rickets and osteomalacia in the Terry Collection using data derived from de la
Cova (2008).
3.7.7

Terry Collection - AMTL
The prevalence of AMTL for skeletons estimated to be male in the MSA sample was

compared to the prevalence of AMTL for males the Terry Collection using data derived from de
la Cova (2008).
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CHAPTER IV
RESULTS
To address the research questions posed in this investigation, a variety of Fisher’s Exact
tests were used. In some cases, a p-value of 1 was produced. A p-value of 1 can be interpreted in
multiple ways. First, a p-value of 1 can indicate that that the likelihood of a type II error for that
contingency table is high, which means that the results show a non-significant relationship when
in fact a significant relationship exists. Second, it can indicate equifinality, which cannot be
resolved with the available data. This means that the proportions present in the contingency table
could be reached in a number of ways (e.g., multiple paths to one end point), which impedes the
ability to assess relationships within the contingency table in a meaningful way. The increased
likelihood of a type II error or equifinality is most frequently found in small sample sizes, such
as those seen here. Therefore, when the resulting p-value was 1 and the proportions in the
contingency table were not identical, the Fisher’s Exact tests were considered to be an invalid
test for that contingency table and no conclusions were made regarding the association between
those two variables.
4.1

Associations Between Frailty and Age
To address research questions 1 and 1.a., the calculated SFI and sub-type SFIs were each

tested for statistically significant associations with age by category (<30 years, 30-50 years, and
51+ years) using Fisher’s Exact tests (Table 4.1). The Overall SFI and the Infection SFI
produced p-values of 1, indicating that the sample size was too small for this test to produce
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valid results. Therefore, no conclusions can be drawn regarding the relationship between age and
the Overall SFI or between age and the Infection SFI. There was no statistically significant
relationship between the Nutrition SFI and age (p=.6351) or the Activity SFI and age (p=.1071)
either. Based on these results, Hypothesis 1 and 1.a. can be rejected.
Table 4.1

Summary table of Fisher’s Exact tests for the SFI’s vs. Age
Index
Overall SFI
Nutrition SFI
Activity SFI
Infection SFI

Contingency Table
Table F.1
Table F.2
Table F.3
Table F.4

Degrees of Freedom
8
2
6
4

p-value
1
.6351
.1071
1

To address research question 1.b. the prevalence of each biomarker was assessed for
statistically significant associations with age using Fisher’s Exact tests (Table 4.2). This was not
done for biomarkers that were not observed in the MSA sample (e.g. neoplasms, osteoporosis,
rickets/osteomalacia). Further, relationships between age and LEH, PD, periosteal reactions, and
OA produced p-values of 1, indicating that the sample size was too small for these tests to
produce valid results. Therefore, no conclusions can be drawn regarding the relationship between
age and these biomarkers. These tests further indicate that there is not a statistically significant
relationship between age and PH or IVD. Only RCD demonstrates a statistically significant
relationship with age (p=.02747). Specifically, older individuals in both the 30-50 and 51+ age
categories are more likely to have RCD than individuals under 30 years of age at death. Based on
these results, Hypothesis 1b is rejected. There is variance in the degree to which each biomarker
varies with age.
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Table 4.2

Summary table for Biomarker vs. Age Fisher’s Exact test results
Biomarker

Contingency
Table
LEH
Table F.5
PD
Table F.6
Periosteal reactions
Table F.7
PH
Table F.8
OA
Table F.9
IVD
Table F.10
RCD
Table F.11
Significant p-values indicated with an asterisk

Degrees of Freedom

p-value

2
2
2
2
2
2
2

1
1
1
.647
1
.6729
.02747*

To address research question 1.c., the contingency tables used to address question 1 and
1.a. (Table F.5-F.11) were divided by sex (Table F.12, Table F.13, Table F.14, Table F.15, Table
F.16, Table F.17, Table F.18, Table F.19), when sample size allowed, and tested for sexdependent associations between frailty and age (Table 4.3). Contingency tables that included
entire rows or columns with zero values were only tested if the contingency table remained 2X2
or larger once the empty rows and columns were removed. Table F.19 did not meet this criterion
and therefore was not tested. Additionally, only the Nutrition SFI for skeletons estimated to be
female (Table F.14) and the Activity SFI for those estimated to be male (Table F.17) produced pvalues other than 1. Neither of these indices were significantly associated with age (Table 4.3).
Therefore, it can be tentatively concluded that there is no sex-dependent difference in the
association between age and frailty. Hypothesis 1.c. can be rejected.
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Table 4.3

Summary table of results for Fisher’s Exact tests for SFI’s vs. Age

Index

Overall SFI
Nutrition SFI
Activity SFI
Infection SFI

Sex
(estimated
skeletal
sex)
Female
Male
Female
Male
Female
Male
Female

Contingency
Table

Degrees of
Freedom

p-value

Table F.12
Table F.13
Table F.14
Table F.15
Table F.16
Table F.17
Table F.18

2
2
1
1
2
3
2

1
1
.2424
1
1
.6786
1

To further explore research question 1.c. the contingency tables that were used to address
research questions 1.b. (Table F.20, Table F.21, Table F.22, Table F.23, Table F.24, Table F.25,
Table F.26, Table F.27, Table F.28, Table F.29, Table F.30, Table F.31, Table F.32, Table F.33)
were divided by sex, when sample size allowed, and tested for sex-dependent associations
between each biomarker and age. Contingency tables that included entire rows or columns with
zero values were only tested if the contingency table remained 2x2 or larger once the ‘zero’ rows
and columns were removed. Table F.23 and Table F.25 did not meet this criterion and therefore
were not tested. Most of the completed tests produced p-values of 1, indicating that the sample
size was too small for this test to produce valid results (Table 4.4). Only RCD produced valid
results for both sex categories, but both p-values were insignificant. This indicates that there is
no sex-based difference in the prevalence of RCD.
Given that the statistical analysis for the relationship between LEH and age (Table F.5)
produced an invalid result, Hypothesis 1.d. cannot be tested and therefore no conclusions can be
made regarding the degree to which LEH is associated with increased morbidity and mortality.
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Table 4.4

Summary table for Fisher’s Exact tests for Biomarkers vs. Age divided by sex

Index
LEH
PD
Periosteal reactions
PH
OA
IVD
RCD

Sex
(estimated skeletal sex)
Female
Male
Female
Female
Female
Male
Female
Male
Female
Male
Female
Male

Contingency
Table
Table F.20
Table F.21
Table F.22
Table F.24
Table F.26
Table F.27
Table F.28
Table F.29
Table F.30
Table F.31
Table F.32
Table F.33

Degrees of
Freedom
1
1
1
1
1
1
1
1
1
1
1
1

pvalue
1
1
1
1
1
1
1
1
1
1
.25
.4286

To understand sex-dependent patterns of mortality, a Fisher’s Exact test was run to assess
the relationship between sex and age-at-death (Table F.34). This test shows that there is no
statistically significant association between age and sex in this sample (p=.1056).
4.2

Associations Between Frailty and Sex
To address research questions 2 and 2.a., the calculated Overall SFI and sub-type SFIs

were each tested for statistically significant associations with sex using Fisher’s Exact tests
(Table F.35, Table F.36, Table F.37, Table F.38). There are no statistically significant
associations between any of the frailty indices and sex (Table 4.5). Therefore, hypotheses 2 and
2.a. are rejected.
Table 4.5

Summary table of Fisher’s Exact tests for the SFI’s vs. Sex
Index
Overall SFI
Nutrition SFI
Activity SFI
Infection SFI

Contingency Table
Table F.35
Table F.36
Table F.37
Table F.38
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Degrees of Freedom
4
1
3
2

p-value
.5714
.6828
.6
.1667

To address research question 2.b. and 2.c., the prevalence of each biomarker was assessed
for statistically significant associations with sex using Fisher’s Exact tests (Table F.39, Table
F.40, Table F.41, Table F.42, Table F.43, 0, Table F.45). Assessments of associations between
LEH and sex produced invalid results (p=1), which prevents drawing any conclusions about the
relationship between early-life stress and sex. None of the other biomarkers show a statistically
significant difference between males and females (Table 4.6). Therefore, hypothesis 2.b. is
accepted since none of the biomarkers were found to vary relative to sex categories.
Table 4.6

Summary table of Fisher’s Exact tests for Biomarkers vs. Sex

Biomarker
LEH
PD
Periosteal reactions
PH
OA
IVD
RCD

4.3

Contingency Table
Table F.39
Table F.40
Table F.41
Table F.42
Table F.43
Table F.44
Table F.45

Degrees of Freedom
1
1
1
1
1
1
1

p-value
1
.06061
.3571
.6942
.4909
.6351
.5758

Associations Between Frailty and Early-life Stress
To address research question 3, the calculated Overall SFI and sub-type SFIs were each

tested for statistically significant associations to LEH using Fisher’s Exact test (Table F.46,
Table F.47, Table F.48, Table F.49). The contingency table comparing the Nutrition SFI to LEH
produced a p-value of 1 and therefore no conclusions can be drawn about this association. None
of the other frailty indices are statistically significantly associated with the presence of LEH
(Table 4.7). Therefore, Hypothesis 3 is rejected.

69

Table 4.7

Summary table of results from Fisher’s Exact tests comparing LEH to the frailty
indices.
Index
Overall SFI
Nutrition SFI
Activity SFI
Infection SFI

Contingency Table
Table F.46
Table F.47
Table F.48
Table F.49

Degrees of Freedom
4
1
3
2

p-value
.1964
1
.2641
.1091

To address research question 3.a., the prevalence of each biomarker was assessed for
statistically significant associations with LEH using Fisher’s Exact tests (Table F.50, Table F.51,
Table F.52, Table F.53, Table F.54, Table F.55). The contingency table comparing periosteal
reactions to LEH (Table F.51) produced a p-value of 1 (Table 4.8). Therefore, no conclusions
can be drawn about this association. Only IVD (Table F.54) had a statistically significant
association with LEH (p=.04511) (Table 4.8). This indicates that a positive association exists
between the two variables; specifically, the presence of LEH is more often found in individuals
with IVD and individuals with IVD are more likely to have LEH. Hypothesis 3.a. can be rejected
as the relationship to LEH varied between biomarkers.
Table 4.8

Summary table of the results of Fisher’s Exact tests comparing the prevalence of
biomarkers to LEH prevalence.

Biomarker
Contingency Table
PD
Table F.50
Periosteal reactions Table F.51
PH
Table F.52
OA
Table F.53
IVD
Table F.54
RCD
Table F.55
Significant p-values indicated by an asterisk

Degrees of Freedom
1
1
1
1
1
1

p-value
.1026
1
.7158
.1818
.04511*
.2821

Research question 3.b. could not be addressed using this sample since stunting was not
assessed, due to poor femoral preservation.
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4.4

Resilience Relative to Age, Sex, and Early-life Stress
To address research question 4, each resilience indicator was assessed for statistically

significant associations relative to age, sex, and the presence of LEH. Neoplasms were not
identified in the MSA sample and no ‘active’ cases of PH were diagnosed. Therefore, these
resilience biomarkers were excluded from this section.
4.4.1

Associations Between Resilience and Age
Each resilience indicator was tested via Fisher’s Exact testing for associations with age

(Table F.56, Table F.57, Table F.58). PD is the only indicator to vary significantly with age
(p=.04762) (Table 4.9), with older individuals more likely to have healed PD at the time of death
while younger individuals are more likely to have active PD at the time of death. The status of
periosteal reactions (i.e., active or healed) was not associated with age (Table 4.9). However,
given that the p-value is remarkably close to .05 (p=.06494), with younger individuals having a
higher prevalence of healed lesions, this association should be retested on a larger sample before
more definitive conclusions are made. The association between AMTL and age could not be
meaningfully statistically assessed (p=1) (Table 4.9).
Table 4.9

Summary table of the results of Fisher’s Exact tests comparing the prevalence of
resilience biomarkers to age.

Biomarker
Contingency Table
PD
Table F.56
Periosteal reactions Table F.57
AMTL
Table F.58
Significant p-values indicated by an asterisk.
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Degrees of Freedom
2
2
2

p-value
.04762*
.06494
1

4.4.2

Associations Between Resilience and Sex
Each resilience indicator was tested via Fisher’s Exact testing for associations with sex

(Table F.59, Table F.60, Table F.61). The status of PD and periosteal reactions (e.g., active vs.
healed) was not significantly associated with sex in any case (Table 4.10). The association
between AMTL and sex could not be meaningfully statistically assessed (p=1) (Table 4.10).
Table 4.10

Summary table of the results of Fisher’s Exact tests comparing the prevalence of
resilience biomarkers to sex.

Biomarker
PD
Periosteal reactions
AMTL
4.4.3

Contingency Table
Table F.59
Table F.60
Table F.61

Degrees of Freedom
1
1
1

p-value
.4643
.58
1

Associations Between Resilience and Early-life Stress
Each resilience indicator was tested via Fisher’s Exact testing for associations with early-

life stress, evidenced via LEH (Table F.62, Table F.63, Table F.64). The status of the resilience
biomarkers (e.g., active vs. healed) relative to LEH prevalence could not be meaningfully
assessed in any case given that all resulting p-values were equal to 1 (0). Therefore, the
relationship between resilience and early-life stress cannot be meaningfully investigated here and
Hypothesis 4 cannot be addressed.
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Table 4.11

Summary table of the results of Fisher’s Exact tests comparing the prevalence of
resilience biomarkers to LEH.

Biomarker
PD
Periosteal reactions
AMTL
4.5

Contingency Table
Table F.62
Table F.63
Table F.64

Degrees of Freedom
1
1
1

p-value
1
1
1

Comparative Results: Prevalence in the MSA vs. the Robert J. Terry Collection
The following section outlines the results of comparative analyses with the Terry

Collection.
4.5.1

LEH
Similar to previous results produced by Plemons (2016), this study finds that LEH

prevalence in the MSA sample is significantly lower than LEH prevalence in the Terry
Collection, as calculated by Gengo (2014) and Coolidge (2016). When LEH prevalence in
individuals estimated to be male in the MSA is compared to the prevalence of LEH in males in
the Terry Collection using data derived from de la Cova (2008), there is not a significant
difference between the two samples. However, skeletons estimated to be male in the MSA still
have a lower LEH prevalence than Terry males. Additionally, this lack of a significant difference
may be due to the small sample of skeletons estimated to be male in the MSA and thus may not
be an accurate measure of difference in LEH prevalence between the two samples. Therefore, the
comparison between the larger MSA sample and the data derived from Gengo (2014) and
Coolidge (2016) is considered to be a better measure.
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Table 4.12

LEH Values for the MSA sample and the Terry Collection
Sample
MSA
MSA skeletons
estimated to be male
only
Coolidge (2016)
Gengo (2014)
de la Cova (2008)

Table 4.13

LEH Present
17
4

Total Observed
57
10

Prevalence
.2982
.40

588
102
202

773
175
374

.7607
.5829
.54

Results of LEH Comparison Between Samples

Samples Compared
MSA vs. Gengo (2014)
MSA skeletons estimated to be male only vs. de la
Cova (de la Cova 2008)
MSA vs. Coolidge (2016)
Significant results indicated with an asterisk.
4.5.2

p-value
.0001887*
0.38057669
.00001*

PD
Comparing PD in individuals age 25-55 between the two samples did not produce a

statistically significant result (p=.146307). Analysis comparing PD not specific to age range in
the MSA to PD in the Terry Collection (Gengo 2014) also showed no statistically significant
difference in the prevalence of PD between the two samples. It should be noted that Gengo
(2014) used a method of diagnosis based on measured vertical recession of greater than 2 mm as
well as porous remodeling of the alveolar bone. While this method differs slightly from the
method employed here (Kerr 1988), Gengo’s (2014) use of an adjusted measurement rather than
the 2 mm standard increases the comparability between the two methods.
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Table 4.14

PD Values for the MSA sample and the Terry Collection
Sample
MSA
MSA Ages 25-55
Gengo (2014)

Table 4.15

PD Present
8
3
77

Total Observed
14
4
197

Results of PD Comparison Between Samples
Samples Compared
MSA Ages 25-55 vs. Gengo (2014)
MSA vs. Gengo (2014)

4.5.3

Prevalence
.5714
.75
.3909

p-value
.146307
.183189

Periosteal reactions
Comparison of periosteal reactions on the lower-limb between samples did not generate a

statistically significant result (p=.09492), indicating that there is not a significant difference in
periosteal reactions on the lower-limbs between the two samples (Table 4.17). Comparing
bilateral periosteal reactions on the tibiae between samples did produce a statistically significant
result (p=.00001), with individuals in the Terry Collection significantly more likely to have
bilateral tibial periosteal reactions than those in the MSA. However, when the prevalence of
periosteal reactions not restricted to a specific element or region of the body but instead
including those observed on any skeletal element in the MSA, is compared to the prevalence
provided by Gengo (2014) and Coolidge (2016) for the Terry, the results are not statistically
significant. In sum, these results indicate that there is not a significant difference in the
prevalence of periosteal reactions between the samples, although there is a difference in the
prevalence of bilateral periosteal reactions on the tibia.
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Table 4.16

Periosteal Reaction Prevalence for the MSA sample and the Terry Collection

Sample
MSA
MSA Lower-limb only
MSA Tibiae (bilateral)
Gengo (2014)
Coolidge (2016)

Table 4.17

Reactions
Present
14
5
9
137
367

Total Observed

Prevalence

15
11
25
197
446

.9333
.4545
.36
.6954
.8229

Results of Periosteal Reaction Comparison Between Samples

Samples Compared
MSA Lower-limbs only vs. Gengo (2014)
MSA Tibiae (bilateral) vs. Coolidge (2016)
MSA vs. Gengo (2014)
MSA vs. Coolidge (2016)
Significant p-values indicated with an asterisk.
4.5.4

p-value
.09492
.00001*
.05
.267

PH
The prevalence of PH in the MSA sample was compared to the prevalence of PH in the

Terry Collection using data derived from de la Cova (2008). Since de la Cova only collected
pathological data for males, the prevalence of PH in skeletons estimated to be male in the MSA
was calculated for comparison. This comparison produced a statistically significant result, with
individuals in the Terry Collection much more likely to have PH than those in the MSA.
Table 4.18

PH Prevalence for the MSA sample and the Terry Collection

Sample
MSA
MSA skeletons
estimated to be male only
de la Cova (2008)

PH Present
12
3

Total Observed
43
12

Prevalence
.2791
.25

309

357

.866
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Table 4.19

Results of PH Comparison Between Samples

Samples Compared
MSA (skeletons estimated to be male) vs.
de la Cova (2008)
Significant p-values indicated with an asterisk.
4.5.5

p-value
6.5E-09*

RCD
Statistical comparison of the estimated prevalence of RCD in the Terry Collection and

the prevalence of RCD in the MSA sample showed a statistically significant difference between
the two samples. Also of note, no cases of os acromiale were observed in the MSA sample,
potentially as a result of the fragmentary nature of the remains. The acromial process was rarely
attached to the rest of the scapula and taphonomic damage was common in this region.
Therefore, it is possible that some cases of os acromiale were present in the MSA sample.
Table 4.20

RCD Prevalence for the MSA sample and os acromiale values and RCD estimates
for the Terry Collection

Sample
MSA RCD prevalence
Hunt (2007) prevalence of os acromiale
Hunt (2007) - os acromiale
data adjusted to estimate RCD

Table 4.21

Present
5
133

Total Observed
19
1594

Prevalence
.2631
.0834

903

1594

.5665

Results of RCD Comparison Between Samples

Samples Compared
MSA RCD vs. RCD estimate from Hunt (year)
Significant p-values indicated with an asterisk.
4.5.6

p-value
.00804*

Intervertebral Disc Disease
Statistical comparison of the prevalence of IVD between the two samples produces a

statistically significant result, with individuals in the Terry Collection more likely to have IVD.
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Table 4.22

IVD Prevalence for the MSA sample and DISH values and IVD estimates for the
Terry Collection

Sample
MSA IVD prevalence
Wilczak and Mulhern (2012) –
DISH prevalence
Wilczak and Mulhern (2012) –
Estimated IVD prevalence

Table 4.23

Present
5
69

Total Observed
24
337

Prevalence
.2083
.2047

203

337

.6024

Results of RCD Comparison Between Samples

Samples Compared
MSA RCD vs. IVD estimate from Wilczak and Mulhern (2012)
Significant p-values indicated with an asterisk.
4.5.7

p-value
.00016*

Osteoarthritis
Comparison of OA in males between the two samples produced a statistically significant

result, with individuals in the Terry Collection much more likely to have OA than those in the
MSA. Additionally, the prevalence of OA in the MSA was compared to the data derived from de
la Cova (2008). This also produced a statistically significant result (p=.01314), further
supporting the conclusion that OA is more common in the Terry Collection than in the MSA.
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Table 4.24

OA Prevalence for the MSA sample and the Terry Collection

Sample
MSA
MSA skeletons estimated to be
male Only
de la Cova (2008) - maximum
prevalence (shoulder) in males

Table 4.25

OA Present
9
4

Total Observed
11
8

Prevalence
.8182
.5

361

374

.9652

Results of OA Comparison Between Samples

Samples Compared
MSA skeletons estimated to be male Only vs. de la
Cova (shoulder) in males
MSA vs. De la Cova (shoulder) in males
Significant results indicted with an asterisk.

4.5.8

p-value
.00001*
.01314*

Neoplasms
No cases of neoplasms were diagnosed in the MSA sample in this study. This can be

compared to findings from de la Cova’s (2008) analysis of over 350 individuals in the Terry
Collection, which yielded only one case of ‘cancer’, which was found in an individual who died
at 79 years of age.
4.5.9

Rickets/Osteomalacia
The prevalence of rickets and osteomalacia in the MSA sample was compared to the

prevalence of rickets and osteomalacia in the Terry Collection using data derived from de la
Cova (2008). This comparison found that the difference in the prevalence of rickets and
osteomalacia between the two samples was insignificant. In the MSA, no cases of rickets or
osteomalacia were identified and in the Terry Collection, only 3.74% of the males analyzed had
evidence of rickets or osteomalacia.
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Table 4.26

Rickets/Osteomalacia Prevalence for the MSA sample and the Terry Collection

Sample
MSA
de la Cova (2008)

Table 4.27

Rickets/Osteomalacia Present
0
14

Prevalence
0.00
.03743

Results of Rickets/Osteomalacia Comparison Between Samples
Samples Compared
MSA vs. de la Cova (2008)

4.5.10

Total Observed
50
374

p-value
.727273

AMTL
The prevalence of AMTL for skeletons estimated to be male in the MSA sample was

compared to the prevalence of AMTL for males the Terry Collection using data derived from de
la Cova (2008). This comparison found that the difference in the prevalence of AMTL between
the two samples was significant, with individuals in the Terry Collection more likely to have
AMTL than those in the MSA.
Table 4.28

AMTL Prevalence for the MSA sample and the Terry Collection
Sample
MSA
MSA skeletons
estimated to be male
Only
de la Cova (2008)

Table 4.29

LEH Present
25
8

Total Observed
39
11

Prevalence
.6410
.7272

364

367

.992

Results of AMTL Comparison Between Samples

Samples Compared
MSA skeletons estimated to be male Only vs. de la
Cova (2008)
Significant p-values indicated with an asterisk.
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p-value
.00001*

CHAPTER V
DISCUSSION
5.1

Suggested Use of the SFI
To address the first objective of this study, the following section outlines the adjustments

made to the SFI. These modifications may be of use in future studies that apply the SFI to
skeletal samples of limited size and poor preservation. First, as outlined above, statistical criteria
were used in some cases (e.g., periosteal reactions) to assess whether a biomarker could be
observed. This method may be useful in other samples with poor preservation, but in well
preserved samples, a method that assesses a single element for each biomarker (e.g., LEH
assessed only on the left maxillary canine, periosteal reactions only assessed on the anterior left
tibia) is the most conservative approach. Second, in this study, femoral metrics could not be
collected due to poor preservation. This limited the assessment of early-life stress to only LEH.
Expanding the SFI to include other biomarkers of early-life stress that can be found on multiple
skeletal elements, such as neural canal size (Amoroso and Garcia 2018; Watts 2011) or bilateral
asymmetry in growth (Albert and Greene 1999), would provide a more flexible and
comprehensive way to assess early-life stress in samples with poor preservation.
Third, Schmorl’s nodes were observed in many cases in the MSA sample, but criteria for
including Schmorl’s nodes in the SFI does not exist. Schmorl’s nodes are commonly found in
skeletal samples (Ortner 2003). As discussed above, they can be observed on fragments of
vertebral centra and can thus be identified in poorly preserved skeletal material. While the
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etiology of Schmorl’s nodes is debated, and multiple etiologies may exist, the most commonly
proposed etiologies include mechanical stress (Von Forell et al. 2014), weakening of the
vertebral endplate caused by ischaemic necrosis (Peng et al. 2003), or abnormal vertebral
formation and development (Dar et al. 2010). These etiologies arguably contribute to frailty,
either by reducing mobility, decreasing bone strength (Peng et al. 2003), or indicating early-life
stress (Dar et al. 2010). Although some studies report that Schmorl’s nodes are asymptomatic
(Kyere et al. 2012) the markers still represent a pathological event or process with a potential
physiological impact. Accordingly, future applications or expansions of the SFI should consider
including Schmorl’s nodes in the index.
Fourth, the Fisher’s Exact tests conducted here indicate that not all biomarkers have the
same variance with age. For example, in the MSA, RCD was found to significantly increase with
age, while other biomarkers did not have a significant relationship to age-at-death. Therefore, not
all biomarkers in the SFI equally indicate or reflect increased morbidity and mortality. A high
number of individuals in the MSA without RCD died young, while those with RCD lived longer.
Thus, is it important that future research that employs the SFI explores the relationships between
each biomarker and age-at-death in order to better understand any sample specific associations
that may exist between frailty and age-at-death and interpret these accordingly. Additionally, this
indicates the importance of using ANCOVA tests when possible to adjust for age-related patterns
in frailty (Marklein and Crews 2017; Marklein et al. 2016).
Fifth, given the flexible nature of the SFI, researchers comparing frailty across samples or
between studies must confirm that the same biomarkers were included in the indices being
compared and that the involved pathologies were diagnosed using identical, or at least similar,
criteria. For example, it would be inappropriate to compare an SFI created for one sample that
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includes periosteal reactions, RCD, IVD, PD, PH, and LEH, to an SFI created for a different
sample that includes OA, femoral length, and fractures. In order to compare SFIs between
samples, the SFIs must be made up of the same biomarkers, assessed according to the same
standards. Therefore, researchers must be explicit in regards to which biomarkers they use to
construct SFIs and should, when conditions permit, share their raw data with other researchers so
that different indices can be constructed to increase the comparability of frailty indices between
samples or across studies.
5.2

Skeletal Frailty in the MSA
The small sample size and poor preservation of the MSA sample presented several

significant limitations to this study. As discussed in the previous section, some biomarkers (e.g.,
femoral length, femoral head diameter) were unobservable within the sample. Additionally, other
biomarkers (e.g., LEH, RCD, PD) were unobservable in many cases. In this way, poor
preservation significantly reduced the sample available for statistical analysis, particularly when
sex and age could not be estimated. Primarily, this small sample size limited the types of
statistical tests that could be used. While ANCOVA and ANOVA tests, which have been
previously used to understand the demographic trends of frailty (Marklein and Crews 2017;
Marklein et al. 2016), are preferred, these tests were not possible here due to small sample size.
However, using Fisher’s Exact tests, some statistical results could still be produced.
5.2.1

Age-Related Trends in Frailty in the MSA
The first research question posed in this study concerned the relationship between age-at-

death and frailty. Specifically, it was hypothesized that there would be a significant correlation
between age-at-death and overall frailty and that each individual biomarker would vary with age83

at-death. Additional hypotheses posed that females, who tend to have greater resilience, would
have both higher frailty and greater resilience at older ages. Additionally, it was hypothesized
that individuals with evidence of early-life stress (i.e. LEH) would die at significantly younger
ages.
Regarding the relationship between frailty and age overall, no significant relationship was
identified. For cases in which an SFI or biomarkers produced a p-value of 1 when assessed for
associations with age (i.e. Overall SFI, Infection SFI, LEH, PD, Periosteal reactions, OA) these
results should be considered invalid. No conclusion about age associations can be made in these
cases. The indices that produced valid p-values (i.e. Nutrition SFI and Activity SFI) did not have
a significant relationship with age. This result was additionally not significant when the data
were divided by sex. The lack of significant associations between age and frailty is initially
surprising given that frailty generally varies with age (DeWitte 2010; DeWitte 2017; DeWitte
and Bekvalac 2010). This expected relationship is in part because, overall, older individuals have
experienced a greater number of stressors, leading to higher frailty and higher resilience with
age. The lack of age-related changes in frailty in this sample may indicate that patients in the
MSA had low resilience. Based on a combination of transcribed admission and discharge records
(Patient registers) and Death Certificates for asylum patients, from 1894 to 1912, the average age
of admission was 41.41 years and the average age at death was 45.68 years, with 4.27 being the
average length of stay. Therefore, the lack of a relationship between frailty and age may indicate
low resilience following admission to the MSA, with some patients dying faster than skeletal
lesions could form (Wood et al. 1992). The abundance of individuals under 30 years of age
(n=23) as compared to individuals over 30 (n=7) in the MSA skeletal sample further supports the
conclusion that resilience was low. However, it is also possible that the lack of age-related
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patterns of frailty in the MSA may be due to the small sub-sample size of individuals over 30
years old (n=7). This conclusion will be discussed further below in section 5.2.4 and section
5.2.5.
Not all biomarkers have the same relationship with age-at-death in the MSA sample. Of
the biomarkers that could be assessed (i.e. PH, IVD, RCD), only RCD was significantly
correlated with age but was insignificant when divided by sex. This age relationship is
unsurprising given that full-thickness tears in the rotator cuff muscles and/or their associated
tendons and ligaments are irreversible without surgical intervention and/or extensive (2+ years)
physical therapy (Kuhn et al. 2013; Tashjian 2012) while partial-thickness tears still require
treatment such as corticosteroid injections (Koester et al. 2007) and extensive physical therapy
for both treatment and pain management. Therefore, without significant medical intervention,
RCD is in part, a degenerative condition (Tashjian 2012). Accordingly, the number of
individuals with RCD in any population should increase with age.
The lack of a significant relationship between age and PH is relatively unsurprising given
that most individuals develop PH during early-life rather than adulthood (Walker et al. 2009).
This result may indicate that the physiological processes underlying PH impacted morbidity and
mortality during childhood but that, in surviving individuals in the MSA, these physiological
processes did not significantly impact experiences of health in adulthood. Similarly, IVD does
not have a significant relationship with age in the MSA sample. This may indicate that for the
individuals of the MSA sample, the likelihood of developing IVD did not increase with age in
adults and that IVD did not significantly contribute to morbidity and mortality.
Given that most of the statistical analyses of sex specific associations between age and
frailty produced invalid results, it should only be tentatively concluded that sex does not
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influence age-related variance in frailty within the MSA. However, a larger sample size—
provided by future, anticipated excavations at the cemetery of the MSA—should be tested before
this conclusion can be fully supported.
Finally, the relationship between LEH and age-at-death could not be meaningfully
statistically assessed. Therefore, no conclusions about the impact of early-life stress on life
expectancy for MSA patients can be drawn. When a larger skeletal sample from the MSA
becomes available following future excavations, this relationship should be reassessed.
5.2.2

Sex-Related Trends in the MSA
The second research question posed in this study concerns associations between frailty

and sex. It was expected that females would have higher frailty, although LEH was expected to
occur at equal rates between the sexes. Additionally, all biomarkers were expected to occur more
frequently in females. However, none of the frailty indices or biomarkers were significantly
associated with sex. The only outlier was LEH, which could not be meaningfully tested
statistically. This result is largely unexpected. Generally, females and are expected to have
higher frailty scores on account of experiencing more stressors as a result of reproduction and
gender-based discrimination, but are expected to be more resilient due to generally greater sexbased physiological resilience to these stressors. When gender is under consideration, women are
expected to have higher frailty scores due to gender-based discrimination. In short, females are
expected to both experience and survive a greater number of stressors than males and should thus
have higher frailty (Eyigor et al. 2015; Gordon et al. 2017) and, skeletally, a higher prevalence of
healed pathologies. The relationship between sex and early-life stress could not be meaningfully
statistically assessed. Therefore, it is unclear if differences in early-life stress between the sexes
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may account for the similarities in age-at-death and resilience observed in this sample, for
instance that female resilience is decreased due to a higher prevalence of LEH in females.
As noted above, skeletons estimated to be male were evaluated relative to those estimated
to be female to assess sex-based differences. Further, gender was reconstructed based on skeletal
sex. Accordingly, an assumption was made that any gender-based differences in frailty and
resilience would follow a bimodal distribution, given the contemporaneous binary gender system
in Mississippi. Relatively little is known about gender-based differences in treatment and living
conditions within the Asylum. What is known is that wards were segregated by gender (i.e.
Women, Men) (Lampton 2017 [2018]). Furthermore, as at other Asylums in the U.S. that cared
for both White and African American (i.e. ‘Negro’/‘Colored’) patients (Grob 1973),
‘Negro’/‘Colored’ women were expected to complete domestic work while ‘Negro’/‘Colored’
men were assigned more physically demanding tasks, such as farming and maintenance work
when compared to their White counterparts at the MSA (Barringer 2016). Biennial reports for
the MSA indicate that the majority of patients in the 1920s and 1930s were ‘Negro’/’Colored’
(Mitchell 1919; Mitchell 1933), which, in addition to overall higher mortality for
‘Negro’/’Colored’ patients at the MSA during this time (Plemons 2016; Zuckerman 2019),
means that many of the individuals in the MSA sample were identified as ‘Negro’/‘Colored’
before and during institutionalization. Importantly, many historical demographic and
bioarchaeological analyses of Antebellum, enslaved populations and Reconstruction and Jim
Crow-era African American populations show that women and men endured at least equivalent
levels of labor and physical activity, whether as domestic laborers or farmhands (Blakey and
Rankin-Hill 2016; Fogel and Engerman 1995 [1997]; Handler and Corruccini 1983; Jones 2010;
Watkins 2003).
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Therefore, the lack of difference in activity related biomarkers (e.g., osteoarthritis)
between male and female skeletons may be reflective of the general lack of gendered differences
in physical activity and labor in contemporary populations, despite the existence of a gendered
division of labor. In other words, the gendered division of labor led men and women to do
different tasks, but the physiological impacts of these tasks was the same across the genders.
This interpretation is further complemented by the lack of evidence for differences in activity
related biomarkers, which may indicate that the activity related stress for these individuals was
similar prior to institutionalization in the MSA as well. This highlights that different stressors
(e.g., different labor activities) can produce similar stress responses and subsequent physiological
impacts.
Again translating sex into gender, the lack of sex-based variation in frailty and the
presence of biomarkers may indicate that women in the Reconstruction and Jim Crow-era
Mississippi and the Deep South, both pre-institutionalization in the MSA were not subjected to
more stressors due to gender-based discrimination than men were. However, many types of
evidence clearly indicate that gender-based discrimination played a major role in women’s lives
in the late 19th and early 20th century in Mississippi and the Deep South. For instance, women
were largely barred from access to contraception (Columbia Law Review Association Inc. 1937),
denied voting rights, and paid less than a man’s minimum wage (Persons 1915). Thus, it is
unlikely that women did not encounter gender-based discrimination prior to or during
institutionalization. Therefore, it is possible that within the MSA, men were subjected to a
greater number of stressors, specifically physiological stressors associated with intense physical
labor. It is possible that frailty does not vary by sex in the MSA skeletal sample because women
were subjected to more stressors (e.g., psychosocial) outside of the MSA while males were
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subjected to more stressors (e.g., physical, activity) inside the MSA, thus leveling the amount of
stress experienced over the life course between the two sexes. While this explanation does not
take into account generally greater resilience in females (Gordon et al. 2017), the amount that
increased resilience in females increases the life span may smaller than the age categories used
here (e.g., >50) can detect. Alternatively, these findings are also directly consistent with the
documentary evidence that many of the individuals in the MSA sample were identified as
‘Negro’/’Colored’ during their lives. This is because African American men and women in the
Reconstruction and Jim Crow-era in Mississippi were, to a great extent, united in their
experience of structural violence and racial terror (McMillen 1989; Mitchell 2014). Public health
literature indicates that the structural violence of Jim Crow had an extremely profound effect on
health, levels of stress, morbidity, and mortality of contemporary African Americans, which
stemmed from a variety of processes (Krieger 1990; Krieger 2014; Krieger et al. 2013; Smith
2005). While African American women experienced an additional burden of gender-based
discrimination, the pervasive effects of racism and racist structural violence on stress and frailty
may have swamped out the detectable effects of gender-discrimination on stress and frailty
(Krieger 1990).
5.2.3

Early-Life Stress Relationships in the MSA
This research was ultimately interested in the relationship between early-life stress and

adulthood frailty. It was hypothesized that individuals with early-life stress (i.e. LEH), would
have greater frailty in adulthood and/or reduced resilience. Further, it was hypothesized that all
of the biomarkers would have similar correlations with early-life stress, for instance showing that
the presence of LEH is positively associated with the presence of every other biomarker.
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Statistical analysis of the relationship between LEH and age-at-death produced an invalid
result (p=1). Therefore, no conclusions can be made regarding the role that early-life stress plays
in age-related changes in morbidity and mortality in the MSA sample. Further, statistical
analyses of the relationship between LEH and sex produced invalid results, preventing any
conclusions regarding sex-based physiological differences or, translating sex into gender,
gender-based discrimination in childhood, such as that females develop more LEH because in
childhood they received lower quality food as a result of gender-based discrimination.
None of the frailty indices that could be meaningfully assessed (e.g. Overall SFI, Activity
SFI, Infection SFI) are significantly associated with the presence of early-life stress. This is
surprising, particularly in the case of the Infection SFI, given that early-life stress is known to
dysregulate physiological stress responses with the result of chronic systemic inflammation in
adulthood (Dube et al. 2009; Lockwood et al. 2018). For this same reason it is surprising that PH
was not significantly associated with LEH. This is because studies of modern populations have
shown that nutritional stress, such as the iron-deficiency anemia in early-life that can cause PH,
may also cause the development of LEH (Lopes et al. 2018). This indicates that the cause of
LEH evident in the MSA sample may not be nutritional, or at least may not be iron-deficiency
anemia. Importantly, prolonged experiences of infectious disease during childhood can also
result in the development of LEH (Seow 1991). Given that epidemic childhood infections (e.g.,
mumps, measles, diphtheria) were still very common during the late 19th and early 20th centuries
in the U.S. (Haines 1994; Omran 2005; Zuckerman et al. 2013), including in Mississippi
(Mitchell 2014), it is possible that LEH in the MSA signify that these individuals contracted a
contagious disease during growth and development and experienced consequent physiological
stress, though they survived the event. Next, the lack of a significant association between PD,
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which is an indicator of both local and systemic inflammation, and LEH may indicate that stress
during growth and development that resulted in LEH did not significantly increase the risk of a
systemic inflammatory response in adulthood. However, this interpretation contradicts many of
the findings within the DOHaD paradigm, which as discussed above have detected tight
associations between early-life stress, particularly chronic stress, and chronic dysregulatory
inflammatory responses later in life. Accordingly, an alternative interpretation is that these
findings may indicate that both individuals with and without LEH had low resilience, leading to
their death before skeletal lesions (e.g., PD, periosteal lesions) could form (Wood et al. 1992).
Not all biomarkers had a positive relationship with LEH. It is relatively unsurprising that
OA and RCD are not significantly associated with early-life stress (i.e. LEH), given that these
two biomarkers are largely induced by activity and do not result from dysregulatory
inflammatory responses. However, the significant relationship between LEH and IVD is
surprising. IVD occurs when the vertebral disks become irritated and inflamed in response to
overuse. This inflammation causes degeneration of the joint, leading to compression of the
vertebrae (Beattie 2008). While disc degeneration may be repaired by growth factors,
macrophages, and mast cells (Baogan et al. 2006), clinical studies have found early-life stress
can dysregulate that this repair response into adulthood (Miller et al. 2011). Therefore, higher
rates of IVD in adult individuals with LEH in the MSA sample may indicate that the stressor that
caused the LEH also led to dysregulation of immune responses that then were inadequate for
combatting IVD in adulthood. It is unusual however, that dysregulation of the inflammatory and
immune response would not also impact the prevalence of PD and periosteal reactions, both of
which are inflammatory conditions. Therefore, this is an unlikely explanation.
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Alternatively, the association between LEH and IVD may be attributable to epigenetics.
Specifically, it might indicate that the individuals in the MSA sample might derive from
biological populations that have a higher prevalence of alleles associated with an increased risk
for IVD and early-life stress. Several alleles that are responsible for cartilage synthesis are
known to be associated with increased risk of IVD (e.g., COL9A2, COL9A3, COL11A2, and
IL6) (Kalichman and Hunter 2008; Virtanen et al. 2007) are also known to undergo epigenetic
changes in gene expression and matrix synthesis when impacted by stress during fetal
development (Herlofsen et al. 2013). Therefore, individuals with fetal stress may incur
epigenetic changes that increase the risk of IVD. In conditions where this stress is chronic or
episodic, and it continued into childhood growth and development, these same individuals may
develop LEH. Unfortunately, no studies have assessed these alleles across populations,
specifically studies which indicate increased risk in African American populations (Kelempisioti
et al. 2011). Other studies have demonstrated population-based differences in genetic
predisposition to alleles associated with IVD, but the alleles investigated are not known to be
impacted significantly by fetal stress (Chan et al. 2006).
Alternatively, the relationship between LEH and IVD in the MSA sample may indicate
that these results support DOHaD, specifically the change model, which predicts that upward
socioeconomic mobility from childhood to adulthood increases access to better nutrition and
health care, leading to more positive health outcomes (Cohen et al. 2010). Specifically,
individuals in the MSA who experienced early-life stress sufficient to cause LEH then
experienced later life stress in the form of intensive physical activity, resulting in the
development of IVD in adulthood. In this case, it is a lack of change (e.g., lack of upward
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mobility and improved living conditions) which may be the sources of the IVD-LEH relationship
found here.
The overall lack of association between LEH and adulthood frailty and disease may
further support the previous conclusion that some individuals in the MSA were dying faster than
biomarkers related to conditions acquired while institutionalized could form (Wood et al. 1992).
Additionally, many individuals did not live long enough to develop certain age-related
conditions such as osteoporosis, osteoarthritis, or neoplasms. Therefore, younger individuals
have equal or fewer biomarkers than do older individuals. Thus, the younger individuals merit a
lower SFI and lower biomarker prevalence. In this case, younger individuals were so frail that
they died rapidly, with little resilience.
An alternative explanation is that while individuals with LEH in the MSA sample
experienced early-life stress, they experienced upward socioeconomic status or otherwise
improved living conditions in adulthood. These improved conditions may have lessened the
long-term physiological impact of early-life stress. It is known that conditions in the MSA were
far from ideal (Barringer 2016). Additionally, elite whites were institutionalized at the East
Mississippi Asylum, rather than at the MSA. Rather, this sample likely overwhelmingly
represents African American individuals, a population known to have suffered declining health
conditions following the Civil War (Carson 2009; de la Cova 2011; Meeker 1976; Rose 1989).
Therefore, improved living conditions are an unlikely explanation for the lack of relationship
between LEH and adulthood frailty in this MSA sample.
5.2.4

Resilience in the MSA
Given the physiological relationship between frailty and resilience, one cannot be

considered without the other. In this study, the relationships between resilience and age, sex, and
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early-life stress were assessed. It was hypothesized that individuals with markers of early-life
stress will have a lower resilience score overall as they are less able to cope with stressors.
When each resilience marker was assessed relative to age, only PD was statistically significantly
associated with age. In this case, having active PD significantly increased the likelihood of dying
young. This suggests that there was an increased risk of morbidity and mortality associated with
ongoing (i.e., active) systemic inflammation and a correspondingly decreased risk when this
inflammation was survived. This result aligns with clinical and bioarchaeological (Berger and
Wang 2017; DeWitte 2014; O'Donnell 2019) literature and is a sign of resilience within the
individuals of the MSA sample. However, the presence of active periosteal reactions was not
associated with an increased risk of morbidity and mortality. This may indicate that surviving
active periosteal reactions (e.g., periosteal reactions are healed at time of death) did not offer a
decreased risk of morbidity or mortality. However, the current sample size may have skewed
these results and, without a larger sample, resolving this issue is extremely difficult. Instead, the
relationship between periosteal lesion status and age at death should be investigated on the
larger, anticipated future sample from the MSA before conclusions can be made regarding the
risk of morbidity and mortality associated with active periosteal reactions. This is especially true
given that the associated p-value in this study was very close to .05, which would indicate
statistical significance.
The status of PD and periosteal reactions were not significantly associated with sex,
indicating that both sexes were equally likely to both have and to heal from these lesions. This is
surprising given that females are generally more resilient (Eyigor et al. 2015; Gordon et al.
2017). However, this finding does align with the above finding that there is no sex difference in
frailty or biomarker prevalence in this sample. This finding further supports the conclusion that
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males may have experienced an increased number or higher load of stressors within the MSA
due to the gendered division of labor and of wards. Finally, the relationship between resilience
and early-life stress could not be assessed in this sample. This association should be further
explored in future studies of the MSA sample, particularly after further excavations are
conducted, which will increase the available sample size.
5.2.5

Frailty in the MSA Relative to the Terry Collection
Finally, in order to understand how experiences of health within the MSA sample,

prevalence data for each of the biomarkers was compared to published data from the Terry
Collection given its comparable temporal and spatial context (Coolidge 2016; de la Cova 2008;
Gengo 2014; Hunt and Bullen 2007). This sample includes individuals who also faced systemic
economic disenfranchisement and race-based discrimination (see Background). Overall, these
results show that in some ways, individuals in the MSA sample were less frail, such as in having
a lower prevalence of biomarkers, than their counterparts in the Terry Collection. However, as is
discussed below in section 5.2.5.2, the perceived lesser frailty and thus greater ‘health’ of the
MSA sample is likely a façade for decreased resilience. In general, the higher prevalence of
biomarkers in the Terry Collection is likely a result of the greater resilience of individuals in this
sample and their associated longer life spans. The comparison between these two samples
highlights the importance of the interpretation that not all skeletal individuals without
pathological skeletal lesions or other skeletal or oral indicators of stress (i.e. “clean” skeletons)
were healthy and free of disease prior to death. Instead, they may have been so frail that they
died before such markers of stress and disease could form (Wood et al. 1992). This is particularly
true for individuals with “clean” skeletons who died at a young age (Goodman 1993).
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5.2.5.1

Early-Life Stress: Differences in LEH, PH, and Rickets
This study finds that LEH and PH prevalence in the MSA sample is significantly lower

than LEH prevalence in the Terry Collection. While methods differed slightly between the
studies used for comparison and the methods employed here, this difference cannot explain the
differences in LEH prevalence between the MSA and the Terry Collection. Rather, given that
more conservative estimation methods used on the Terry—Gengo (2014) observed only the
maxillary incisors and mandibular canines and Coolidge (2016) observed only the canines—a
lower rate of LEH in the Terry Collection would be expected. Differently, de la Cova assessed
all present teeth, as did the present study, so the prevalence found by de la Cova and the
prevalence found in this study are expected to be more comparable. However, data from all three
authors reveals a higher prevalence of LEH in the Terry Collection, with significantly higher
prevalences reported by Coolidge (2016) and Gengo (2014). To address methodological
differences (e.g., only males were assessed for de la Cova’s dissertation (2008)), the prevalence
of PH in skeletons estimated to be male in the MSA was compared to the prevalence of PH in
males the Terry Collection using data derived from de la Cova (2008).
Given that both LEH and PH are significantly more common in the Terry Collection, it is
possible this difference is the result of migration patterns in the populations represented by these
samples. Specifically, as noted above, many individuals in the Terry Collection are African
American, and migrated to the American Midwest and North from the Deep South as part of the
Great Migration in the late 19th and early 20th centuries. In turn, the many individuals in the
MSA who were likely African American, based on institutional records from the MSA, primarily
represent individuals who were still residents in Mississippi at the time of their
institutionalization. Individuals who experienced early-life stress but had few chances for upward
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mobility may have been more likely to migrate to Missouri, which ultimately resulted in being
included in the Terry Collection. This possibility is supported by studies which find that African
Americans were more likely than whites to have low socioeconomic status (SES) during the
early twentieth century (Flynt 1989) and that African Americans with low SES are known to
migrate further the their white counterparts on average in search of upward mobility (Rose 1958)
and education (Tolnay 1998). The high rates of LEH and PH in the Terry Collection therefore
may indicate that individuals who migrated to Missouri experienced early-life stress and low
socioeconomic status in childhood and were barred from upward mobility in their home states
during adulthood. Evidence suggests that individuals who are economically disadvantaged or
fear violence in their home communities are highly motivated to migrate, including those who
moved during the Great Migration (Harrison 1991; Rose 1958). Therefore, individuals with less
upward mobility may have been more likely to migrate from Mississippi and other Southern
states to Missouri during the Great Migration in order to achieve greater socioeconomic stability
(Harrison 1991; Tolnay 1998). The Terry Collection then may represent individuals who were
the most disadvantaged in their home communities (de la Cova 2019), increasing the likelihood
that they would have experienced early-life stress, causing higher rates of LEH.
Overall, this study shows that individuals in the Terry Collection experienced greater
rates of early-life stress (e.g., higher prevalence of LEH and PH). In adulthood, these individuals
show a higher prevalence of RCD, IVD, OA, and AMTL. Although this signals that
individuals in the Terry Collection were more frail, their long lifespans signal that they had high
resilience. In addition to the explainations provided above, greater resilience in the Terry
Collection may support and be explained by the ‘healthy migrant effect’. Several studies have
shown that migrants are healthier than the source populations they came from (Chen 2011;
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Vandenheede et al. 2015). However, other studies find varying (Thomson et al. 2013), weak
(Rubalcava et al. 2008), or non-existant (Andersson and Drefahl 2017)corrleations between
health status and migration. Additionally, some researchers find that although migrants are
healthier then their source population, this increased health status may be temporary as migrants
are more likely to be of low socioeconomic status, have worse living conditions, and have
limited access to health care compared to the population they joined (Chen 2011; Fennelly 2007;
Hesketh et al. 2008; Lechner and Mielck 1998; Norredam et al. 2014). Facing these barriers and
experiencing decreasing health following migration is also known to motivate many migrants to
move back to their original communities (Andersson and Drefahl 2017; Razum et al. 1998;
Zhang et al. 2015).
Given that the Terry Collection individuals had higher rates of LEH and PH, both of
which are associated with stress in early-life, the healthy-migrant effect seems an unlikely
explaination for the elevated resilience of Terry Collection individuals. Additionally, there is no
evidence for the healthy-migrant effect during the Great Migration but several studies suggest
that individuals who faced discrimination, feared violence, or had limited upward socioeconomic
mobility were more likely to move (Harrison 1991; Rose 1985; Tolnay 1998), directly
contradicting the healthy-migrant effect.
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Arguably, the lack of rickets and osteomalacia in both samples may indicate that
nutritional stress was isolated to iron deficiencies, which cause PH, while vitamin D deficiencies
were less common. Given that corn was a dietary staple in the South, particularly among poor
whites and African Americans, and within the MSA (Mississippi State Lunatic Asylum 1884;
Mississippi State Lunatic Asylum 1888)the prevalence of iron deficiencies is not surprising
given that corn interferes with iron absorption (Charlton and Bothwell 1983), particularly in the
absence of meat. Additionally, hookworm was common in the New South, with 40% of the
southern population infected in 1905 (Martin and Humphreys 2006), and is known to cause iron
deficiency anemia (Foy and Kondi 1960). Therefore, endemic hookworm likely contributed
significantly to the prevalence of PH in these samples. Given that individuals in the Terry
Collection have a higher prevalence of LEH and PH, their living conditions may have been less
sanitary given that poor sanitation contributes to infectious disease prevalence, including
hookworm (Martin and Humphreys 2006).
5.2.5.2

Differences in Oral Health, Inflammation, and Resilience: PD, AMTL, and
Periosteal reactions
The lack of a significant difference in PD prevalence between the MSA and the Terry

Collection indicates that systemic inflammatory conditions that are known to be associated with
PD, such as cardiovascular disease, cancer, diabetes, obesity, and respiratory infections (e.g.,
Hollister and Weintraub 1993; Irwin et al. 2008; Johnson et al. 2006; Li et al. 2000; Pihlstrom et
al. 2005; Slots 2004; Williams et al. 2008), may have occurred at similar rates in the two
samples. Notably, the dental and periodontal medicine literature shows that AMTL is most
commonly caused by PD in modern populations (Hillson 2001). Given this, it is interesting that
despite the lack of difference in PD prevalence between the two samples, AMTL does differ
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significantly. This is likely a product of individuals in the Terry Collection having an older ageat-death than those in the MSA. This older age represents a longer span of time for PD to have
developed and worsened, which would have increased the chance of AMTL (Hillson 2001).
Ultimately, increased rates of AMTL in the Terry Collection indicate that these individuals are
significantly more resilient as they survived PD at a higher rate.
The difference in the prevalence of periosteal reactions between the MSA and Terry
samples produced varying results depending on the specific data used for comparison. When
periosteal reactions of the lower-limb were compared between samples, the result was not
significant. However, when the prevalence of periosteal reactions specific to the tibiae was
compared, the result was significant. Additionally, non-element specific comparisons, such as
the frequency of periosteal reactions observable throughout the body for the MSA sample
compared to lower-limb and tibia specific periosteal reactions in the Terry Collection, are not
significant. The stark difference between the prevalence of periosteal reactions in the lower-limb
(20%) as compared to the overall prevalence of periosteal reactions (93.3%) in the MSA may
indicate that methods that only include observation of periosteal reactions on the lower-limb or
only the tibiae may greatly underestimate the prevalence of periosteal reactions throughout the
body. Therefore, the true accuracy of element-specific analyses, such as only analyzing the tibia
for periosteal reactions, as a proxy for full-body observation should be further investigated in
large, well-preserved samples. However, it can tentatively be concluded that individuals in the
Terry Collection had an increased prevalence of periosteal reactions when compared to the MSA.
This is likely the result of greater resilience in these individuals, as is evidenced by higher rates
of AMTL and longer average life spans, during which a greater number of stressors were
experienced and survived. Alternatively, this may indicate that the most common cause of
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periosteal reactions differs between the two samples. However, given that periosteal reactions
have a multitude of causes (Crespo et al. 2017; Klaus 2014; Ortner and Putschar 1981; Weston
2008; Weston 2009), this cannot be definitively concluded.
The prevalence of RCD also varies between the Terry Collection and the MSA sample.
Specifically, the estimated prevalence of RCD in the Terry Collection was significantly higher
than the prevalence of RCD in the MSA sample. This may mean that the likelihood of
developing RCD was decreased for individuals in the MSA as a result of relatively lighter labor
requirements, either within the MSA (Barringer 2016) or prior to institutionalization. While
‘Negro’/ ‘Colored’ patients were expected to work inside the MSA, white patients were not
(Barringer 2016). Therefore, RCD may be higher in ‘Negro’/‘Colored’ patients in the MSA
sample, with lower rates in white patients, due to disparities in labor requirements. Low rates of
RCD in white patients would then decrease the overall prevalence of RCD in the MSA, leading
to a comparably low prevalence of RCD in the MSA as compared to the Terry Collection.
Considerations of RCD prevalence that are divided by social race may produce more equivalent
prevalence of RCD between African Americans in the two samples.
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CHAPTER VI
CONCLUSIONS
There are several notable strengths of this study. First, cumulative measures of ‘health’
are difficult to obtain, both on the individual and population level. However, the recent
development of the SFI (Marklein et al. 2016) has granted researchers a way in which to assess
lifelong experiences of health in individuals and to sum these experiences in a way that still
maintains individual-level data and limits homogenization of the study sample into populationlevel data. Therefore, the SFI provided a mechanism for assessing heterogeneous frailty, such as
is conducted in this study. Additionally, the use of recent (Barringer 2016) and historical
publications (Mississippi State Asylum 1884; Mississippi State Asylum 1888) detailing the
history of the MSA and the conditions experienced by patients in the Asylum have allowed for
the findings of this study to be meaningfully contextualized within an ecosocial and biocultural
framework.
Finally, the use of skeletal remains allows researchers to study longitudinal, lifelong
experiences of health, which is not easily done in living populations. The DOHaD paradigm is
difficult to investigate in living populations for many reasons. These include vocabulary
differences between medical records (i.e., change over time), participant attrition, cost, and the
length of study time needed for both retrospective and prospective longitudinal studies (Thomson
and Holland 2003). Additionally, living individuals often experience heterogeneous ecosystems
throughout their life courses, including different stressors, living in different places, having
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different jobs, and eating different diets. In contrast, individuals who were institutionalized at the
MSA and were buried in the MSA cemetery at least experienced the shared ecosystem of the
MSA during the last portion of their lives, even though diets, workloads, and the conditions of
the wards, amongst other factors, may have varied to a certain extent across the patient
population (Mitchell 1919; Mitchell 1933). Additionally, while they derived from different
regions of Mississippi and came from diverse socioeconomic backgrounds, many individuals in
the MSA in the early 20th century belonged to the poor laboring class and/or wereAfrican
American (Mitchell 1919; Mitchell 1933). Therefore, variation in adulthood stressors was
minimized to some extent, allowing for analyses to focus on the impact of early-life stress on
adulthood frailty, although length of institutionalization played a role as well. Additionally,
skeletal investigations of stress in bioarchaeology focus on the physiological impacts of
stressors, rather than the stressors themselves or how individuals perceived these stressors. This
allows for the physiological impacts of early-life stress to be studied rather than the perceived
impacts, which is often the measure used in modern clinical studies (e.g., Chao et al. 2019; Dent
et al. 2016; Gahbauer et al. 2008; Xue 2011).
6.1

Main Findings
The SFI was employed in this study to investigate health experiences of individuals who

died in the MSA in the early 20th century, between 1909 and 1935. The impacts of age, sex,
early-life stress, and resilience on individual frailty were explored and compared to roughly
contemporaneous and generally comparable individuals in the Terry Collection. This study
demonstrates that in stressful situations, such as those experienced at least intermittently by some
patients in the MSA, the impacts of early-life stress may be negated by the high stress burden
experienced in adulthood. This may have been particularly true for African Americans at the
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MSA, who endured the structural violence of Jim Crow prior to institutionalization and likely
poorer conditions during institutionalization at the MSA.
Additionally, this study supports the change model of long-term impacts of early-life
stress. This model suggests that the chronic or episodic stress experienced during childhood
growth and development continues into adulthood, creating an environmentally-determined
causation between early-life stress and adulthood frailty. Notably, individuals in the MSA with
and without evidence of early-life stress demonstrated low resilience. This suggests that during
institutionalization in the MSA, biological and social conditions for many patients were so
insalubrious and stressful that fast acting, unregulated stress responses were biologically favored
over more advantageous functional or ‘healthy’ stress responses. This increased the damage and
dysregulation done by stress responses.
The limited resilience of MSA patients is further highlighted when the prevalence of
biomarkers in the MSA sample is compared to that in the Terry Collection. Individuals in the
Terry Collection manifest a higher prevalence of biomarkers (e.g., PD, RCD, LEH), but also had
higher resilience (e.g., AMTL) and longer life spans. This result highlights that, while its
components may sometimes be difficult to address, the osteological paradox must be considered
and accommodated in all studies of skeletal pathologies (DeWitte and Stojanowski 2015; Wood
et al. 1992). Without this consideration, conclusions may be the inverse of the lived experiences
of the individuals in the samples under study. Specifically, as this study shows, individuals
without evidence of skeletal pathologies or skeletal and oral stress markers are not always
‘healthy’.
While the biological and social conditions experienced by many economically and
politically marginalized communities in the South were often stressful, this study shows that life
104

was especially harsh for those who were institutionalized in the MSA and included in the MSA
skeletal sample. This is reflected in early-life stress and frailty and reduced resilience in
adulthood, including while institutionalized at the MSA. In particular, comparison with
individuals in the Terry Collection shows that patients in the MSA sample were less resilient
towards the end of their lives, potentially as a result of biological and social conditions in the
MSA.
6.2

Limitations
The most significant limitation in this study was sample size. Only 68 individuals have

been excavated from the MSA potter’s field to date. This represents only a small fraction of the
greater than 7,000 individuals thought to be buried there (Cureton et al. 2014) and the nearly
10,000 individuals who died in the MSA. Additionally, this sample only includes individuals
who died between 1909 and 1935 (Cureton et al. 2014) and therefore excludes individuals who
lived in the Asylum during its first four decades (Mississippi State Asylum 1884; Mississippi
State Asylum 1888). Importantly, these earlier decades were characterized by a higher load of
infectious disease, though a lower burden of chronic and degenerative conditions (Dafoe et al.
2019; Zuckerman et al. 2014), as well as very different structural and environmental conditions
(e.g., internal heat, drinking water sources, lighting sources) (Mississippi State Asylum 1884;
Mississippi State Asylum 1888). Because of this, the results of this study should not be
extrapolated to characterize life in the MSA prior to 1909.
Additionally, the small sample size limited the statistical assessment of the data. For
example, ANCOVA/ANOVA tests, which would have corrected for age related changes in the
biomarkers and would have provided a higher level of statistical analyses, could not be used. The
results of many of the Fisher’s Exacts tests conducted in this study were invalid, producing p105

values of 1, which indicates equifinality and therefore invalidity. As a consequence of this, many
of the associations between biomarkers and frailty indices of interest in this study (e.g., LEH vs.
age at death) could not be assessed. In terms of future research, this study should be expanded as
skeletal excavations proceed and the available sample size from the MSA increases.
Finally, the results of this study and future studies of the MSA sample should be
compared to additional skeletal samples that represent institutionalized and non-institutionalized
individuals throughout the U.S.. This study did not attempt a broader comparison due to the high
number of biomarkers investigated here and the lack of comparability to other samples (e.g.,
temporal, spatial). Future research, such as that employing a smaller number of biomarkers in
skeletal frailty indices, might fruitfully pursue this avenue.
6.3

Future Directions
Future studies should address the shortcomings of this study, specifically the small

sample size, the poor preservation of the skeletal remains, and the limited comparison with other
skeletal samples. Specifically, future studies should engage in comparison of the MSA sample to
additional samples that represent a range of institutionalized and non-institutionalized individuals
over a broader range of time. These would help to situate frailty and resilience in the MSA
within a broader lens.
Additionally, while the DOHaD paradigm is interdisciplinary and has wide empirical
support, further investigations and applications of this paradigm can identify shortfalls of the
DOHaD paradigm and its applications to both modern and past populations (Baird et al. 2017;
Gowland 2015). In other words, only by repeatedly testing hypotheses generated from the
DOHaD paradigm will we come to understand circumstances in which it may not apply or may
be less applicable. This study provides one example of the limited effects of early-life stress on
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adulthood frailty and health experiences in highly stressful environments, such as institutional
contexts. Additionally, further study will contribute to long-term understandings of how the
immunological and physiological relationships described by DOHaD have changed throughout
time in human populations (Klaus 2014) or how this relationship changes over an individual life
course.
In regard to bioarchaeology and paleopathology, this study models one possible way to
employ and manipulate the SFI. Criteria for the use of the SFI are outlined here to provide an
example of the flexibility and limitations of the SFI in a small, poorly preserved sample. Future
implementations of the SFI should explore and expand these criteria. Additionally, a database,
similar to or an extension of the Global History of Health database (Steckel and Rose 2002),
which allows researchers to compare biomarkers and frailty indices across samples, would
enhance the utility of the SFI.
6.4

Broader Impacts
Via publication, the findings of this study, and others like it (e.g., Armelagos et al. 2009;

Bellis et al. 2015; Coolidge 2016; Goodman and Armelagos 1988; Power and Peckham 1990;
Turner et al. 2016), can inform public health efforts, including studies of the Global Burden of
Disease which “provides a tool to quantify health loss from hundreds of diseases, injuries, and
risk factors, so that health systems can be improved and disparities can be eliminated” (Institute
for Health 2019). They can also encourage meaningful action towards the prevention of early-life
stress, as well as legislation that enables upward mobility and aids marginalized and
disenfranchised populations and encourages humane treatment of modern-day institutionalized
individuals (e.g., via imprisonment). Additional investigations addressing population variation in
early-life stress and its lifelong impacts will better inform the wide-scale implementation of
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preventative measures that identify susceptible sub-populations for targeted prevention and
treatment interventions.
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Raw data (e.g., sex, age, biomarker assessment) for the 67 individuals analyzed in
this study
Biomarker Assessment
of Status
(e.g. active or
healing/healed)

IVD

RCD

PD Status

Neoplasm
Status

AMTL

19

1

0

0

1

0

0

1

0

0

0

0

2

0

0

2

Indet.

x

0

x

x

0

0

x

x

x

0

x

0

0

0

0

3

Male

15

0

x

1

1

0

0

0

0

0

x

2

2

0

2

4

Female

31.6

1

1

1

1

0

0

1

0

1

2

2

2

x

0

5

Female

x

0

x

x

0

0

x

x

x

x

x

2

0

0

2

6

Male

59.1

1

1

1

0

0

0

1

1

1

2

2

0

0

2

7

Male

26.1

0

1

1

1

0

0

1

0

0

1

2

2

0

2

8

Male

29.7

1

x

1

0

0

0

1

1

1

x

2

0

0

0

9

Indet.

x

1

x

x

0

0

x

x

x

x

x

2

0

0

2

10

Indet.

25

0

x

x

0

x

x

x

x

x

x

0

0

0

2

11

Indet.

15

0

x

x

1

0

x

x

x

x

x

0

2

0

x

12

Male

15

0

x

x

0

0

x

x

x

x

x

2

0

0

x

13

Male

15

0

x

x

0

x

x

x

x

x

x

2

0

0

2

Periosteal
reactions
PH

Female

PD

1

Burial #

OA

Rickets &
Osteomalaci
a
Neoplasms

Age:
Transition
analysis
point
estimate
LEH

Sex Estimate

Biomarker Assessment of
Presence/Absence

Periosteal
Lesion
Status
PH
Status

Table A.1
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Table A.1 (continued)
Biomarker Assessment
of Status
(e.g. active or
healing/healed)

IVD

RCD

PD Status

Neoplasm
Status

AMTL

x

x

0

0

x

x

x

x

x

0

0

0

2

15

Indet.

x

0

x

x

0

0

x

x

x

x

x

0

0

0

x

16

Indet.

33.3

0

x

x

0

0

x

x

x

x

x

2

0

0

2

17

Indet.

x

0

x

x

x

x

x

x

x

x

x

0

x

0

x

18

Indet.

x

0

x

x

x

0

x

x

x

x

x

0

x

0

x

19

Indet.

x

0

x

x

x

0

x

x

x

x

x

0

x

0

x

20

Indet.

x

x

x

x

x

x

x

x

x

x

x

0

x

0

x

21

Indet.

x

0

x

x

x

x

x

x

x

x

x

0

x

0

x

22

Indet.

x

0

x

x

x

x

x

x

x

x

x

x

x

x

x

23

Indet.

x

x

x

x

0

x

x

x

0

x

x

0

0

0

2

24 Female

15

0

x

x

1

0

x

x

x

x

x

0

2

0

x

25 Female

x

1

x

x

0

0

x

x

0

x

x

2

0

0

2

26 Female

32

x

x

x

1

0

x

x

x

x

x

1

2

0

2

27

x

x

x

x

x

x

x

x

x

x

x

0

x

0

0

28 Female

19.7

1

x

x

0

0

x

x

1

x

x

0

0

0

2

29 Female

15

x

x

x

0

x

x

x

x

x

x

0

0

0

2

Indet.
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Periosteal
Lesion
Status
PH
Status

OA

0

Rickets &
Osteomalaci
a
Neoplasms

x

Periosteal
reactions
PH

Indet.

PD

Sex Estimate

14

Age:
Transition
analysis
point
estimate
LEH

Burial #

Biomarker Assessment of
Presence/Absence

Table A.1 (continued)

IVD

RCD

PD Status

Neoplasm
Status

AMTL

1

1

1

1

0

0

x

0

x

1

2

2

0

0

31

Male

15

x

x

x

0

0

x

x

0

x

x

2

0

0

2

32

Male

x

1

1

1

0

0

0

x

0

x

1

1

0

0

0

33

Male

15

1

1

1

1

0

0

1

0

0

1

2

2

0

x

34

Male

15

1

1

1

0

0

0

1

1

1

1

2

0

0

2

35 Female

15

0

x

x

1

0

x

x

0

x

x

2

2

0

x

36 Female

x

1

x

x

x

0

x

x

1

x

x

2

x

0

2

37 Female

20.9

0

0

1

0

0

0

0

0

0

0

2

0

0

0

38

Male

30.1

0

1

1

0

0

0

1

0

0

1

2

0

0

0

39

Male

50.5

0

x

1

0

0

0

1

0

1

x

1

0

0

2

29.3

1

x

1

0

0

0

x

0

0

x

2

0

0

x

x

0

x

x

x

0

x

x

x

x

x

0

x

0

x

38.1

x

x

x

0

0

x

x

0

x

x

2

0

0

2

15

0

x

x

0

0

x

x

x

x

x

0

0

0

x

44 Female

x

x

x

x

x

x

x

x

x

x

x

0

x

0

2

45

x

0

x

x

x

0

x

x

x

x

x

0

x

0

x

40 Female
41

Indet.

42 Female
43

Indet.

Indet.

Periosteal
reactions
PH

15

PD

30 Female

Burial #

OA

Rickets &
Osteomalaci
a
Neoplasms

Age:
Transition
analysis
point
estimate
LEH

Sex Estimate

Biomarker Assessment of
Presence/Absence

Periosteal
Lesion
Status
PH
Status

Biomarker Assessment
of Status
(e.g. active or
healing/healed)
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Table A.1 (continued)
Biomarker Assessment
of Status
(e.g. active or
healing/healed)

IVD

RCD

PD Status

Neoplasm
Status

AMTL

0

x

0

0

x

x

0

0

0

0

0

0

2

47

Indet.

x

0

x

x

x

0

x

x

0

0

x

0

x

0

x

48 Female

x

0

0

x

0

0

x

x

0

x

0

2

0

0

x

49

Amb.

15

1

x

x

0

0

x

x

x

0

x

2

0

0

x

50

Indet.

x

0

x

x

1

0

x

x

x

x

x

2

2

0

0

51

Indet.

x

0

x

x

x

0

x

x

x

x

x

0

x

0

x

52 Female

x

0

x

x

0

0

x

x

x

x

x

2

0

0

x

53 Female

x

0

x

x

0

x

x

x

x

x

x

2

0

0

2

54

x

1

x

x

x

0

x

x

x

x

x

0

x

0

x

55 Female

15

0

x

x

0

0

x

x

x

x

x

2

0

0

2

56 Female

x

1

x

x

x

0

x

x

x

x

x

0

x

0

2

57 Female

x

0

x

x

x

0

x

x

x

x

x

0

x

0

0

58

Indet.

x

0

x

x

x

x

x

x

x

x

x

0

x

0

x

59

Indet.

x

0

0

x

0

x

x

x

x

x

0

1

0

0

0

60

Indet.

x

x

x

x

x

x

x

x

x

x

x

0

x

0

x

61

Indet.

x

0

x

x

x

x

x

x

x

x

x

0

x

0

x

Indet.
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Periosteal
Lesion
Status
PH
Status

OA

0

Rickets &
Osteomalaci
a
Neoplasms

26.9

Periosteal
reactions
PH

Amb.

PD

Sex Estimate

46

Age:
Transition
analysis
point
estimate
LEH

Burial #

Biomarker Assessment of
Presence/Absence

Table A.1 (continued)
Biomarker Assessment
of Status
(e.g. active or
healing/healed)

IVD

RCD

PD Status

Neoplasm
Status

AMTL

x

x

x

x

x

x

x

x

x

0

x

0

x

63

Indet.

x

1

x

x

x

0

x

x

x

x

x

0

x

0

x

64

Indet.

x

0

0

1

x

0

0

x

x

x

0

2

x

0

0

65

Indet.

x

0

x

x

x

0

x

x

x

x

x

0

x

0

0

66

Male

x

x

x

x

x

0

x

x

x

x

x

0

x

0

2

67

Indet.

15

x

x

x

1

x

x

x

x

x

x

2

2

0

x

Periosteal
Lesion
Status
PH
Status

OA

0

Rickets &
Osteomalaci
a
Neoplasms

x

Periosteal
reactions
PH

Indet.

PD

Sex Estimate

62

Age:
Transition
analysis
point
estimate
LEH

Burial #

Biomarker Assessment of
Presence/Absence

Legend: For the Presence/Absence assessments of biomarkers (x) indicates was unobservable
and could not be assessed, (0) indicates that the biomarker was absent, (1) indicates that the
biomarker was present. Point age estimates are provided here, but age range estimates were also
calculated.
Data regarding femoral measurements and osteoporosis are excluded given that these biomarkers
were not included in the analysis of this study.
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OA

IVD

RCD
Modified
Overall SFI

Neoplasms

Rickets &
Osteomalaci
a
PH

PD

0

0

0

0

1

1

0

0

2

1

1

0

0

1

1

0

1

5

1

1

0

0

0

1

1

1

5

1

1

0

0

1

1

0

0

4

Periosteal
reactions

Sex

Age

Data used to create and assess the Overall Skeletal Frailty Index

Burial #

Table B.1

4

Femal
e
Femal
e

6

Male

7
3
3
3
4
3
7
3
8

Male

19
31.
6
59.
1
26.
1

Male

15

1

1

0

0

1

1

0

0

4

Male
Femal
e

15
20.
9
30.
1

1

1

0

0

0

1

1

1

5

1

0

0

0

0

0

0

0

1

1

1

0

0

0

1

0

0

3

1

Male
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Table C.1

Data used to create and assess the Nutritional Skeletal Frailty Index
Indiv #
1
2
3
4
5
6
7
8
9
11
12
14
15
16
24
25
26
28
30
31
32
33
34
35
37
38
39
40
42
43
46
48
49
50
52
55

Sex
Female
Indeterminate
Male
Female
Female
Male
Male
Male
Indeterminate
Indeterminate
Male
Indeterminate
Indeterminate
Indeterminate
Female
Female
Female
Female
Female
Male
Male
Male
Male
Female
Female
Male
Male
Female
Female
Indeterminate
Ambiguous
Female
Ambiguous
Indeterminate
Female
Female

Age
19
x
15
31.6
x
59.1
26.1
29.7
x
15
15
x
x
33.3
15
x
32
19.7
15
15
x
15
15
15
20.9
30.1
50.5
29.3
38.1
15
26.9
x
15
x
x
15

PH
1
0
1
1
0
0
1
0
0
1
0
0
0
0
1
0
1
0
1
0
0
1
0
1
0
0
0
0
0
0
0
0
0
1
0
0
137

Rickets &
Nutrition
Osteomalacia Index
0
1
0
0
0
1
0
1
0
0
0
0
0
1
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
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Table D.1

Data used to create and assess the Activity Skeletal Frailty Index

Indiv #
1
3
4
6
7
8
33
34
37
38
39

Sex
Female
Male
Female
Male
Male
Male
Male
Male
Female
Male
Male

Age
19
15
31.6
59.1
26.1
29.7
15
15
20.9
30.1
50.5

OA IVD RCD
1
0
0
0
0
0
1
0
1
1
1
1
1
0
0
1
1
1
1
0
0
1
1
1
0
0
0
1
0
0
1
0
1

139

Activity
SFI
Score
1
0
2
3
1
3
1
3
0
1
2

APPENDIX E
INFECTION SKELETAL FRAILTY INDEX
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Table E.1

Data used to create and assess the Infection Skeletal Frailty Index

Indiv #
1
4
6
7
30
32
33
34
37
38
64

Sex
Female
Female
Male
Male
Female
Male
Male
Male
Female
Male
Indet.

Age
19
31.6
59.1
26.1
15
x
15
15
20.9
30.1
x

Perioste
al
reaction
s
0
1
1
1
1
1
1
1
1
1
1
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PD
0
1
1
1
1
1
1
1
0
1
0

Neoplam
s
0
0
0
0
0
0
0
0
0
0
0

Infectio
n Index
0
2
2
2
2
2
2
2
1
2
1
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Table F.1

Overall SFI vs Age Categories
SFI 1
SFI 2
SFI 3
SFI 4
SFI 5

Table F.2

>50 years
0
0
0
0
1

<30 years
12
8

30-50 years
2
2

>50 years
2
0

<30 years
2
4
0
2

30-50 years
0
0
1
0

>50 years
0
0
1
1

30-50 years
0
0
1

>50 years
0
0
1

Activity SFI vs Age
SFI 0
SFI 1
SFI 2
SFI 3

Table F.4

30-50 years
0
0
0
0
1

Nutrition SFI vs Age
SFI 0
SFI 1

Table F.3

<30 years
1
1
1
2
1

Infection SFI vs Age
SFI 0
SFI 1
SFI 2

<30 years
1
1
5

143

Table F.5

LEH Prevalence vs Age
LEH Absent
LEH Present

Table F.6

<30 years
13
8

30-50 years
0
1

>50 years
0
2

30-50 years
2
2

>50 years
2
0

30-50 years
0
1

>50 years
0
2

30-50 years
2
0

>50 years
1
1

OA vs Age
<30 years
Absent 2
Present 6

Table F.10

>50 years
0
1

PH vs Age
<30 years
Absent 15
Present 9

Table F.9

30-50 years
0
1

Periosteal reactions vs Age
<30 years
Absent 1
Present 9

Table F.8

>50 years
1
1

PD Prevalence vs Age
<30 years
Absent 3
Present 4

Table F.7

30-50 years
1
1

IVD vs Age
<30 years
Absent 11
Present 3

144

Table F.11

RCD vs Age
<30 years
Absent 9
Present 2

Table F.12

30-50 years
0
0
0
0
1

>50 years
0
0
0
0
0

<30 years
0
0
1
2
1

30-50 years
0
0
0
0
0

>50 years
0
0
0
0
1

30-50 years
1
2

>50 years
0
0

30-50 years
0
0

>50 years
2
0

Females - Nutrition SFI vs Age
SFI 0
SFI 1

Table F.15

<30 years
1
1
0
0
0

Males - Overall SFI vs Age Categories
SFI 1
SFI 2
SFI 3
SFI 4
SFI 5

Table F.14

>50 years
0
2

Females - Overall SFI vs Age Categories
SFI 1
SFI 2
SFI 3
SFI 4
SFI 5

Table F.13

30-50 years
0
1

<30 years
4
4

Males - Nutrition SFI vs Age
SFI 0
SFI 1

<30 years
5
3

145

Table F.16

Females - Activity SFI vs Age
SFI 0
SFI 1
SFI 2
SFI 3

Table F.17

<30 years
1
3
0
2

30-50 years
0
0
0
0

>50 years
0
0
1
1

<30 years
1
1
1

30-50 years
0
0
1

>50 years
0
0
0

30-50 years
0
0
0

>50 years
0
0
1

Males - Infection SFI vs Age
SFI 0
SFI 1
SFI 2

Table F.20

>50 years
0
0
0
0

Females - Infection SFI vs Age
SFI 0
SFI 1
SFI 2

Table F.19

30-50 years
0
0
1
0

Males - Activity SFI vs Age
SFI 0
SFI 1
SFI 2
SFI 3

Table F.18

<30 years
1
1
0
0

<30 years
0
0
4

Female - LEH Prevalence vs Age
LEH Absent
LEH Present

<30 years
4
4

146

30-50 years
0
1

>50 years
0
0

Table F.21

Male - LEH Prevalence vs Age
LEH Absent
LEH Present

Table F.22

<30 years
2
1

<30 years
0
4

>50 years
0
0

30-50 years
0
0

>50 years
0
1

30-50 years
0
1

>50 years
0
0

Male - Periosteal reactions vs Age
<30 years
Absent 0
Present 6

Table F.26

30-50 years
0
1

Female - Periosteal reactions vs Age
<30 years
Absent 1
Present 3

Table F.25

>50 years
1
1

Male - PD Prevalence vs Age
PD Absent
PD Present

Table F.24

30-50 years
0
0

Female - PD Prevalence vs Age
PD Absent
PD Present

Table F.23

<30 years
5
3

30-50 years
0
0

>50 years
0
2

30-50 years
1
2

>50 years
0
0

Female - PH vs Age
<30 years
Absent 5
Present 4

147

Table F.27

Male - PH vs Age
<30 years
Absent 6
Present 3

Table F.28

30-50 years
0
0

>50 years
0
2

30-50 years
2
0

>50 years
0
0

30-50 years
0
0

>50 years
1
1

30-50 years
0
1

>50 years
0
0

Male - IVD vs Age
<30 years
Absent 5
Present 2

Table F.32

>50 years
0
0

Female - IVD vs Age
<30 years
Absent 5
Present 1

Table F.31

30-50 years
0
1

Male - OA vs Age
<30 years
Absent 1
Present 5

Table F.30

>50 years
2
0

Female - OA vs Age
<30 years
Absent 1
Present 1

Table F.29

30-50 years
0
0

Female - RCD vs Age
<30 years
Absent 3
Present 0
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Table F.33

Male - RCD vs Age
<30 years
Absent 4
Present 2

Table F.34

Table F.36

Table F.37

>50 years
0
2

30-50 years
3
0

>50 years
0
2

Age vs Sex in the MSA sample
<30 years
Female 9
Male 9

Table F.35

30-50 years
0
0

Overall SFI vs Sex
SFI 1
SFI 2
SFI 3
SFI 4
SFI 5

Female
1
1
0
0
1

Male
0
0
1
2
2

SFI 0
SFI 1

Female Male
9
8
6
3

SFI 0
SFI 1
SFI 2
SFI 3

Female
1
1
1
0

Nutrition SFI vs Sex

Activity SFI vs Sex
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Male
1
3
1
3

Table F.38

Infection SFI vs Sex
SFI 0
SFI 1
SFI 2

Table F.39

Female
1
1
2

LEH Prevalence vs Sex
LEH Absent
LEH Present

Table F.40

Female Male
9
6
8
5

PD Prevalence vs Sex
PD Absent
PD Present

Table F.41

Female Male
3
0
2
6

Periosteal reactions vs Sex
Periosteal reactions
Absent
Periosteal reactions
Present

Table F.42

Male
0
0
5

Female
1

Male
0

4

9

PH vs Sex
PH Absent
PH Present

Female
11
6

150

Male
9
3

Table F.43

OA vs Sex
OA Absent
OA Present

Table F.44

Female
1
2

IVD vs Sex
Female
IVD Absent 9
IVD Present 2

Table F.45

Female
3
1

Male
4
4

Overall SFI vs LEH
SFI 1
SFI 2
SFI 3
SFI 4
SFI 5

Table F.47

Male
7
3

RCD vs Sex
RCD Absent
RCD Present

Table F.46

Male
1
7

LEH Absent
1
0
1
1
0

LEH Present
0
1
0
1
3

LEH Absent
14
6

LEH Present
9
4

Nutrition SFI vs LEH
SFI 0
SFI 1
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Table F.48

Activity SFI vs LEH
SFI 0
SFI 1
SFI 2
SFI 3

Table F.49

LEH Present
0
2
1
3

LEH Absent
0
2
2

LEH Present
1
0
6

Infection SFI vs LEH
SFI 0
SFI 1
SFI 2

Table F.50

LEH Absent
2
2
1
0

PD Prevalence vs LEH

PD Absent
PD Present

Table F.51

LEH
Absent
5
2

LEH
Present
1
6

Periosteal reactions vs LEH

Periosteal reactions
Absent
Periosteal reactions
Present
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LEH
Absent
0

LEH
Present
1

6

8

Table F.52

Table F.53

Table F.54

PH vs LEH

PH Absent
PH Present

LEH
Absent
18
9

LEH
Present
6
4

OA Absent
OA Present

LEH
Absent
2
3

LEH
Present
0
6

OA vs LEH

IVD vs LEH
LEH
Absent
IVD Absent 9
IVD Present 0

Table F.55

RCD vs LEH

RCD Absent
RCD Present

Table F.56

LEH
Present
7
5

LEH
Absent
7
4

LEH
Present
1
4

Contingency table used to assess the relationship between PD activity status and
age.
PD Active
PD Healed

<30
5
0

30-50
0
1
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>50
0
1

Table F.57

Contingency table used to assess the relationship between periosteal lesion activity
and age.
Periosteal Lesion
Active
Periosteal Lesion
Healed

Table F.58

30-50
1

>50
1

16

3

1

Contingency table used to assess the relationship between AMTL status and age.
AMTL Absent
AMTL Present

Table F.59

<30
0

<30
4
10

Female
1
1

Male
5
1

Contingency table used to assess the relationship between periosteal lesion activity
and sex.
Periosteal Lesion
Active
Periosteal Lesion
Healed

Table F.61

>50
0
2

Contingency table used to assess the relationship between PD activity status and
sex.
PD Active
PD Healed

Table F.60

30-50
1
3

Female
1

Male
2

13

10

Contingency table used to assess the relationship between AMTL status and sex.
AMTL Absent
AMTL Present

Female
5
11
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Male
3
8

Table F.62

Contingency table used to assess the relationship between PD activity status and
LEH.

PD Active
PD Healed

Table F.63

LEH
Present
4
2

Contingency table used to assess the relationship between periosteal lesion activity
and LEH.

Periosteal Lesion
Active
Periosteal Lesion
Healed
Table F.64

LEH
Absent
2
0

LEH
Absent
2

LEH
Present
1

15

11

Contingency table used to assess the relationship between AMTL status and LEH.

AMTL Absent
AMTL Present

LEH
Absent
8
11

155

LEH
Present
5
7

